<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">54792</article-id><article-id pub-id-type="doi">10.7554/eLife.54792</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Gut Helicobacter presentation by multiple dendritic cell subsets enables context-specific regulatory T cell generation</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-169768"><name><surname>Russler-Germain</surname><given-names>Emilie V</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2036-6697</contrib-id><email>russler@wustl.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-216509"><name><surname>Yi</surname><given-names>Jaeu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-171212"><name><surname>Young</surname><given-names>Shannon</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-171213"><name><surname>Nutsch</surname><given-names>Katherine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-171214"><name><surname>Wong</surname><given-names>Harikesh S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-171215"><name><surname>Ai</surname><given-names>Teresa L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-171216"><name><surname>Chai</surname><given-names>Jiani N</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2560-8218</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-171217"><name><surname>Durai</surname><given-names>Vivek</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-58344"><name><surname>Kaplan</surname><given-names>Daniel H</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12225"><name><surname>Germain</surname><given-names>Ronald N</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1495-9143</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-1933"><name><surname>Murphy</surname><given-names>Kenneth M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-171218"><name><surname>Hsieh</surname><given-names>Chyi-Song</given-names></name><email>chsieh@wustl.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Internal Medicine, Division of Rheumatology, Washington University School of Medicine</institution><addr-line><named-content content-type="city">St. Louis</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Pathology, Division of Immunobiology, Washington University School of Medicine</institution><addr-line><named-content content-type="city">St. Louis</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Dermatology, Department of Immunology, Pittsburgh Center for Pain Research, University of Pittsburgh</institution><addr-line><named-content content-type="city">Pittsburgh</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>MacPherson</surname><given-names>Andrew J</given-names></name><role>Reviewing Editor</role><aff><institution>University of Bern</institution><country>Switzerland</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Garrett</surname><given-names>Wendy S</given-names></name><role>Senior Editor</role><aff><institution>Harvard T.H. Chan School of Public Health</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>03</day><month>02</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e54792</elocation-id><history><date date-type="received" iso-8601-date="2019-12-30"><day>30</day><month>12</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2021-01-22"><day>22</day><month>01</month><year>2021</year></date></history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-54792-v2.pdf"/><abstract><p>Generation of tolerogenic peripheral regulatory T (pTreg) cells is commonly thought to involve CD103<sup>+</sup> gut dendritic cells (DCs), yet their role in commensal-reactive pTreg development is unclear. Using two Helicobacter<italic>-</italic>specific T cell receptor (TCR) transgenic mouse lines, we found that both CD103<sup>+</sup> and CD103<sup>–</sup> migratory, but not resident, DCs from the colon-draining mesenteric lymph node presented Helicobacter antigens to T cells ex vivo. Loss of most CD103<sup>+</sup> migratory DCs in vivo using murine genetic models did not affect the frequency of Helicobacter-specific pTreg cell generation or induce compensatory tolerogenic changes in the remaining CD103<sup>–</sup> DCs. By contrast, activation in a Th1-promoting niche in vivo blocked Helicobacter-specific pTreg generation. Thus, these data suggest a model where DC-mediated effector T cell differentiation is ‘dominant’, necessitating that all DC subsets presenting antigen are permissive for pTreg cell induction to maintain gut tolerance.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>regulatory t cell</kwd><kwd>Helicobacter</kwd><kwd>microbiota</kwd><kwd>dendritic cell</kwd><kwd>tolerance</kwd><kwd>colon</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AI079187</award-id><principal-award-recipient><name><surname>Hsieh</surname><given-names>Chyi-Song</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AI136515</award-id><principal-award-recipient><name><surname>Hsieh</surname><given-names>Chyi-Song</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000861</institution-id><institution>Burroughs Wellcome Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hsieh</surname><given-names>Chyi-Song</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F30 DK111071</award-id><principal-award-recipient><name><surname>Russler-Germain</surname><given-names>Emilie V</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 GM007200</award-id><principal-award-recipient><name><surname>Russler-Germain</surname><given-names>Emilie V</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>In vitro and in vivo studies show that multiple dendritic cell subsets are capable of presenting gut Helicobacter antigens to induce regulatory T cells.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The intestinal immune system is required to balance maintaining tolerance to commensal bacteria while preserving the capability of mounting an inflammatory response to pathogenic bacteria. Commensal bacterial induction of tolerogenic peripheral regulatory T (pTreg) cells, and not pro-inflammatory effector T cells, appears to be important for preserving immune homeostasis and health and preventing the development of inflammatory bowel disease (IBD) (<xref ref-type="bibr" rid="bib5">Blander et al., 2017</xref>; <xref ref-type="bibr" rid="bib34">Imam et al., 2018</xref>; <xref ref-type="bibr" rid="bib64">Shale et al., 2013</xref>).</p><p>A substantial body of evidence suggests that the process by which naïve CD4<sup>+</sup> T cells are selected to be pTreg vs effector T cells is directed by specific conventional dendritic cell (cDC) subsets. For example, cDC1s direct the differentiation of Th1 T cells through their production of IL-12. In a similar fashion, subsets of cDC2s have been shown to be important for both Th2 and Th17 differentiation (<xref ref-type="bibr" rid="bib21">Durai and Murphy, 2016</xref>).</p><p>In the intestine, CD103<sup>+</sup> cDCs comprising both CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s and CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s are commonly thought to induce the differentiation of pTreg cells from naïve T cells (<xref ref-type="bibr" rid="bib29">Hasegawa and Matsumoto, 2018</xref>; <xref ref-type="bibr" rid="bib63">Scott et al., 2011</xref>; <xref ref-type="bibr" rid="bib67">Takenaka and Quintana, 2017</xref>; <xref ref-type="bibr" rid="bib68">Tanoue et al., 2016</xref>). The studies that initially characterized this subset as the predominant pTreg cell-inducting subset of cDCs were primarily done in vitro and determined that the pTreg cell-inducing properties of mixed CD103<sup>+</sup> CD11b<sup>–</sup> cDC1 and CD103<sup>+</sup> CD11b<sup>+</sup> cDC2 populations were dependent on TGF-β, the retinoic acid-producing enzyme retinaldehyde dehydrogenase (RALDH), and the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) (<xref ref-type="bibr" rid="bib17">Coombes et al., 2007</xref>; <xref ref-type="bibr" rid="bib33">Huang et al., 2013</xref>; <xref ref-type="bibr" rid="bib47">Matteoli et al., 2010</xref>; <xref ref-type="bibr" rid="bib66">Sun et al., 2007</xref>). Importantly, the early studies examining CD103<sup>+</sup> cDCs (<xref ref-type="bibr" rid="bib17">Coombes et al., 2007</xref>; <xref ref-type="bibr" rid="bib66">Sun et al., 2007</xref>) were performed before it was appreciated that this population included both cDC1s and a subset of cDC2s. These early studies also did not discriminate between migratory and resident cDC subsets in the mesenteric lymph nodes (MLN) or between CD11c<sup>+</sup> cDCs and macrophages in the colon lamina propria (cLP), therefore confounding comparisons of CD103<sup>+</sup> and CD103<sup>–</sup> cDC subsets in pTreg induction (<xref ref-type="bibr" rid="bib17">Coombes et al., 2007</xref>; <xref ref-type="bibr" rid="bib33">Huang et al., 2013</xref>; <xref ref-type="bibr" rid="bib47">Matteoli et al., 2010</xref>; <xref ref-type="bibr" rid="bib66">Sun et al., 2007</xref>). In addition to these in vitro experiments, in vivo studies have suggested that CD103<sup>+</sup> cDC1s and cDC2s are important for ovalbumin (OVA)-specific pTreg cell differentiation in a model of oral tolerance. Esterhazy et al. used <italic>Zbtb46</italic><sup>Cre</sup>::<italic>Irf8</italic><sup>fl/fl</sup> mice to deplete cDC1s and Mazzini et al. used Itgax-Cre::<italic>Gja1</italic><sup>fl/fl</sup> mice to delete Connexin 43 in all CD11c<sup>+</sup>antigen presenting cells (APCs), finding a defect in antigen presentation by small intestine CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s; however, the conclusion that CD103<sup>+</sup> cDC1s and cDC2s are critical may have been confounded by the deletion of these targeted genes in all cDC subsets (<xref ref-type="bibr" rid="bib22">Esterházy et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Mazzini et al., 2014</xref>). Finally, Welty et al. showed that depletion of CD103<sup>+</sup> cDC1s and cDC2s in CD207-DTA::<italic>Batf3<sup>–/–</sup></italic> mice resulted in decreased polyclonal CD4<sup>+</sup> T cell numbers in the small intestine lamina propria, including Treg cells (<xref ref-type="bibr" rid="bib78">Welty et al., 2013</xref>). Although this latter study cannot address whether CD103<sup>+</sup> cDC1s and cDC2s contributed to pTreg cell induction vs maintenance, these data add to the body of literature supporting the notion that CD103<sup>+</sup> cDC1s and cDC2s are important for pTreg cell induction.</p><p>Recently, this prevailing concept that CD103<sup>+</sup> cDC1s and cDC2s are the primary inducers of pTreg cells in the intestine has been challenged. One study of colonic tolerance to OVA enema showed that protection against delayed-type hypersensitivity (DTH) could be mediated by CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s (<xref ref-type="bibr" rid="bib76">Veenbergen et al., 2016</xref>). As the draining LN of OVA enema are the iliac and caudal LNs, which naturally lack CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s, the use of <italic>Batf3</italic><sup>–/–</sup> mice eliminated the only CD103<sup>+</sup> cDCs in these LNs, the CD103<sup>+</sup> cDC1s. The notion that CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s are sufficient for inducing OVA-specific Treg cells was supported by in vitro experiments, but in vivo OVA-specific Treg induction after OVA enema in <italic>Batf3</italic><sup>–/–</sup> mice was not assessed. Similarly, we previously found that colonic Helicobacter-specific pTreg cell differentiation was unaffected in <italic>Batf3<sup>–/–</sup></italic> mice (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). However, one caveat of our study is that <italic>Batf3</italic>-deficiency may only result in a partial decrease in cDC1s in intestinal tissues (<xref ref-type="bibr" rid="bib73">Tussiwand et al., 2012</xref>) and does not eliminate CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s in the MLN draining more proximal portions of the GI tract. Another study found that MHC Class II expression in CX3CR1<sup>+</sup> mononuclear phagocytes, thought to be a subset apart from CD103<sup>+</sup> cDC1s and cDC2s (<xref ref-type="bibr" rid="bib6">Bogunovic et al., 2009</xref>), is required for pTreg cell induction in oral tolerance and that CX3CR1<sup>+</sup> mononuclear phagocytes are required for pTreg cell differentiation in commensal tolerance in <italic>Rag2<sup>–/–</sup></italic> host mice (<xref ref-type="bibr" rid="bib37">Kim et al., 2018</xref>). These studies therefore argue that non-CD103<sup>+</sup> DCs are important or redundant for Treg cell development. However, it is possible that the ‘tolerogenic’ cDC subset differs for oral or per rectum administered soluble proteins vs. naturally colonized commensal bacterial antigens. Thus, the importance of cDC subsets for the induction of intestinal pTreg cells remains an open area of study (<xref ref-type="bibr" rid="bib53">Mowat, 2018</xref>).</p><p>Previously, we identified two colonic T cell clones (CT2 and CT6) that undergo pTreg cell differentiation in response to distinct Helicobacter (<italic>H.</italic>) species, <italic>H. typhlonius</italic> or <italic>H. apodemus</italic>, respectively (<xref ref-type="bibr" rid="bib15">Chai et al., 2017</xref>). Colonic Helicobacter species reside in close proximity to the intestinal epithelium within the mucous layer in the crypts (<xref ref-type="bibr" rid="bib60">Recordati et al., 2009</xref>) and are classified as pathobionts that cause inflammation in susceptible hosts, yet are pervasive in healthy hosts (<xref ref-type="bibr" rid="bib28">Fox et al., 1999</xref>; <xref ref-type="bibr" rid="bib70">Taylor et al., 2007</xref>). At homeostasis, Zbtb46<sup>+</sup> cDCs are essential for presenting <italic>H. typhlonius</italic> and <italic>H. apodemus</italic> to naïve T cells in the colon-draining distal MLN (dMLN); naïve Helicobacter-specific T cells are not activated in vivo in the absence of cDCs (<xref ref-type="bibr" rid="bib15">Chai et al., 2017</xref>; <xref ref-type="bibr" rid="bib40">Lathrop et al., 2011</xref>; <xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). However, the specific cDC subset that presents Helicobacter antigens to naïve T cells and mediates pTreg cell selection remains unknown.</p><p>Here, we examine the role of cDC subsets in presenting antigens from Helicobacter to naïve T cells and how they influence naïve T cell differentiation. Our data argue against the hypothesis that CD103<sup>+</sup> cDC1s and cDC2s represent specialized cDC subsets required for presentation of gut commensal antigens and pTreg cell induction. Rather, our data support the notion that unlike certain cDC functions, induction of commensal-specific Treg cells in the periphery is not restricted to a specific migratory cDC subset. These data support a model in which pTreg cell development is ‘recessive’ such that all cDCs presenting cognate antigen to a given naïve T cell must be permissive for the induction of FOXP3, and that the presence of antigen-carrying cDCs that induce canonical effector T cell development ‘dominantly’ blocks pTreg cell generation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Migratory cDCs present Helicobacter antigens during homeostasis</title><p>If a specific subset of cDCs facilitates the conversion of commensal-specific T cells into pTreg cells, then this subset should present Helicobacter antigens on MHC Class II. We therefore sought to determine the cDCs that present Helicobacter antigens in vivo. First, we asked whether Helicobacter antigens are presented by cDCs resident in the dMLN vs those that migrate from the colon. Lymph node resident cDCs may acquire soluble antigens either from lymphatic drainage from the colon or transfer from migratory cDCs (<xref ref-type="bibr" rid="bib1">Allan et al., 2006</xref>; <xref ref-type="bibr" rid="bib31">Hor et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Sixt et al., 2005</xref>). In contrast, migratory cDCs have been shown to pick up antigens in the intestine lamina propria through a variety of mechanisms and then move through afferent lymphatics to the draining MLN (<xref ref-type="bibr" rid="bib12">Cerovic et al., 2013</xref>; <xref ref-type="bibr" rid="bib24">Farache et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Mazzini et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">McDole et al., 2012</xref>; <xref ref-type="bibr" rid="bib79">Worbs et al., 2006</xref>).</p><p>To directly examine which of these cDC subsets are loaded with Helicobacter antigen in vivo, we sorted resident (MHC II<sup>int</sup> CD11c<sup>hi</sup>) and migratory (MHC II<sup>hi</sup> CD11c<sup>int</sup>) cDCs (<xref ref-type="bibr" rid="bib61">Satpathy et al., 2012</xref>) from the dMLN and co-cultured them with naïve Helicobacter<italic>-</italic>specific T cell receptor (TCR) transgenic cells that recognize <italic>H. typhlonius</italic> (CT2) or <italic>H. apodemus</italic> (CT6) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib15">Chai et al., 2017</xref>). TCR activation was assessed by CD25 upregulation. We observed that migratory cDCs were much more efficient than resident cDCs at activating both CT2 and CT6 TCR transgenic T cells, as assessed by the percentage of activated CD25<sup>+</sup> cells and CD25 median fluorescence intensity (MFI), a measurement for magnitude of activation within individual cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). When exogenous autoclaved Helicobacter antigens were added to the cultures, resident cDCs were actually more efficient than migratory cDCs at activating naïve T cells, confirming that resident cDCs are fully capable of antigen uptake, processing, and presentation (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Migratory cDC stimulation of T cells was MHC Class II-dependent, as it could be blocked by addition of monoclonal anti-MHC Class II blocking antibody to the culture (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). In summary, these ex vivo data show that migratory, but not resident, cDCs in the dMLN present Helicobacter antigens during homeostasis.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Migratory conventional dendritic cells (cDCs) present Helicobacter antigens to naïve T cells.</title><p>(<bold>A</bold>) Migratory cDCs present endogenously loaded Helicobacter antigens to T cells. Resident (MHCII<sup>int</sup> CD11c<sup>hi</sup>) or migratory (MHCII<sup>hi</sup> CD11c<sup>int</sup>) cDCs from the distal mesenteric lymph node (dMLN) were cultured with naïve (CD44<sup>lo</sup> CD62L<sup>hi</sup> CD4<sup>+</sup>) CT2 or CT6 T cells for 2 days. The percentage of CT2 and CT6 T cells that upregulated CD25 and the CD25 median fluorescence intensity (MFI) of CD25<sup>+</sup> cells were analyzed by flow cytometry (expt. = 3). (<bold>B</bold>) Both resident and migratory cDCs can present exogenous Helicobacter antigens. dMLN resident and migratory cDCs were cultured as in (<bold>A</bold>) with the addition of autoclaved isolates of <italic>H. typhlonius</italic> (CT2) or <italic>H. apodemus</italic> (CT6) (expt. = 3). (<bold>C</bold>) Migratory cDCs are necessary for CT2 and CT6 activation in vivo. Naïve CT2 or CT6 (5 × 10<sup>4</sup>) were injected into littermate <italic>Ccr7<sup>+/–</sup></italic> or <italic>Ccr7<sup>–/–</sup></italic> mice. Transferred cells in the dMLN were analyzed 1 week later for total cells recovered and <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> expression (expt. = 3). Each dot represents an independent experiment except in (<bold>C</bold>), where each dot represents one mouse. Mean ± SEM shown. p-values from Student’s t-test (<bold>A–C</bold>) excluding no cDC condition (<bold>A</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. The following figure supplement is available for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Migratory conventional denditic cells (cDCs) present Helicobacter antigens to naïve T cells.</title><p>(<bold>A</bold>) Representative post-sort analysis of resident (MHCII<sup>int</sup> CD11c<sup>hi</sup>) or migratory (MHCII<sup>hi</sup> CD11c<sup>int</sup>) conventional dendritic cells (cDCs) from the distal mesenteric lymph node (dMLN) used in <xref ref-type="fig" rid="fig1">Figure 1A,B</xref>.</p><p>(<bold>B</bold>) CT2 and CT6 activation ex vivo by migratory cDCs is MHC Class II-dependent. Migratory cDCs from the dMLN were cultured as in <xref ref-type="fig" rid="fig1">Figure 1A</xref> in the absence or presence of blocking MHC Class II antibody (expt. = 3). Each dot represents an independent experiment. Mean ± SEM shown. p-values from Student’s t-test (<bold>B</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig1-figsupp1-v2.tif"/></fig></fig-group><p>We then addressed whether genetic ablation of a receptor necessary for efficient cDC migration would affect CT2 and CT6 T cell activation in vivo. <italic>Ccr7<sup>–/–</sup></italic> mice lack a critical chemokine receptor for cDC trafficking to the lymph node and therefore lack most migratory cDCs in the dMLN (<xref ref-type="bibr" rid="bib51">Mikulski et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Ohl et al., 2004</xref>; <xref ref-type="bibr" rid="bib61">Satpathy et al., 2012</xref>). One week after transfer of naïve TCR transgenic cells into <italic>Ccr7</italic><sup>+/–</sup> or <italic>Ccr7</italic><sup>–/–</sup> mice, we observed a striking decrease in T cell activation, as measured by the number of recovered CT2 and CT6 cells in the dMLN after adoptive transfer, as well as a decrease in the induction of Foxp3<sup>+</sup> CT2 and CT6 cells (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). A caveat of these results is that CCR7 is required for the development of normal lymphoid organ architecture and T cell entry into lymph nodes, resulting in altered immune responses in host mice (<xref ref-type="bibr" rid="bib27">Förster et al., 2008</xref>). Nevertheless, these in vivo <italic>Ccr7<sup>–/–</sup></italic> results are consistent with the ex vivo cDC results described above, and together these data demonstrate an important role of migratory cDCs in the activation of naïve Helicobacter-specific T cells.</p></sec><sec id="s2-2"><title>All migratory cDC subsets present Helicobacter antigens</title><p>We next asked which subset(s) of migratory cDCs are capable of activating naïve CT2 and CT6 T cells. For these studies, we sorted single positive CD103<sup>+</sup> CD11b<sup>–</sup> (CD103<sup>+</sup> SP) cDC1, double positive CD103<sup>+</sup> CD11b<sup>+</sup> (DP) cDC2, and single positive CD103<sup>–</sup> CD11b<sup>+</sup> (CD11b<sup>+</sup> SP) cDC2 subsets of migratory cDCs. We assessed cDC purity using <italic>Zbtb46<sup>GFP</sup></italic> mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>), which express GFP in cDC lineage cells as well as monocyte-derived cDCs during inflammation, but not in macrophages (<xref ref-type="bibr" rid="bib61">Satpathy et al., 2012</xref>). This revealed that about 15–25% of CD103<sup>–</sup> CD11b<sup>+</sup> sorted cells are F4/80<sup>lo/int</sup><italic>Zbtb46</italic><sup>GFP–</sup> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>) and likely represent a macrophage subset with cDC-like antigen presentation functionality (<xref ref-type="bibr" rid="bib13">Cerovic et al., 2014</xref>; <xref ref-type="bibr" rid="bib61">Satpathy et al., 2012</xref>). As our previous study using <italic>Zbtb46<sup>DTR</sup></italic> mice suggested that Zbtb46<sup>–</sup> cells played a minor to negligible role in presentation of Helicobacter antigens in vivo (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>), we expected that these contaminants would not activate CT2/CT6 in our in vitro analysis of CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s.</p><p>Our previous studies showed a defect in CT2 and CT6 pTreg cell differentiation in Itgax-Cre::<italic>Notch2<sup>fl/fl</sup></italic> (Notch2-ΔDC) mice (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). Disruption in NOTCH2 signaling in cDCs results in loss of CD103<sup>+</sup> CD11b<sup>+</sup> DP cDC2s in the MLN, although development and function of other cDC subsets are also altered in these mice (<xref ref-type="bibr" rid="bib41">Lewis et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Satpathy et al., 2013</xref>). Based on these previous data and other studies (<xref ref-type="bibr" rid="bib78">Welty et al., 2013</xref>), we predicted that DP cDC2s would be the primary cDC subset presenting Helicobacter antigens in the dMLN. Unexpectedly, we observed that at least some members of all three subsets of migratory cDCs constitutively presented Helicobacter antigens to naïve CT2 and CT6 T cells using the ex vivo culture approach described above (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Although DP cDC2s tended to activate both CT2 and CT6 naïve T cells to a greater degree than the other two subsets, DP cDC2s only constitute about 15% of migratory cDCs in the dMLN and thus may not represent the dominant cDC subset inducing naïve T cell activation in vivo (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). All three subsets of migratory cDCs had comparable naïve T cell activating potential, as demonstrated by coculturing cDCs with naïve OT-II T cells and varying concentrations of OVA peptide (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). Thus, contrary to our hypothesis, these in vitro data show that all migratory cDC subsets carry Helicobacter antigens from the colon and can present the antigens to naïve CT2 and CT6 T cells in the dMLN.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Multiple subsets of migratory conventional dendritic cells (cDCs) present Helicobacter antigens to naïve T cells at homeostasis.</title><p>All three main subsets of migratory cDCs present endogenous Helicobacter antigens to T cells ex vivo. Migratory CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s (CD103<sup>+</sup> SP), CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s (DP), or CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s (CD11b<sup>+</sup> SP) were sorted from the distal mesenteric lymph node (dMLN) and cultured with naïve CT2 and CT6 T cells as in <xref ref-type="fig" rid="fig1">Figure 1A</xref> (expt. = 5–6). Each dot represents an individual experiment. Mean ± SEM is shown. p-values from Tukey’s multiple comparisons test excluding no cDC condition; *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. The following figure supplement is available for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Multiple subsets of migratory conventional dendritic cells (cDCs) present Helicobacter antigens to naïve T cells at homeostasis.</title><p>(<bold>A</bold>) Antigen presenting cells (APCs) in the CD103<sup>–</sup> CD11b<sup>+</sup> cDC2 (CD11b<sup>+</sup> SP) gate are mostly conventional dendritic cells (cDCs) by <italic>Zbtb46</italic><sup>GFP</sup> expression.</p><p>Representative fluorescence-activated cell sorting (FACS) plots of CD11b<sup>+</sup> SP APCs showing low/intermediate F4/80 expression in <italic>Zbtb46</italic><sup>GFP–</sup> cells. (<bold>B</bold>) Representative post-sort analysis of CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s (CD103<sup>+</sup> SP), CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s (DP), or CD11b<sup>+</sup> SP migratory cDCs from the distal mesenteric lymph node (dMLN) used for experiments in <xref ref-type="fig" rid="fig2">Figure 2</xref>. (<bold>C</bold>) Migratory cDC1s are increased in the dMLN of wild-type mice relative to the proximal MLN. Migratory cDC subset compositions were analyzed by dividing the mesenteric LN chain into six sections, roughly corresponding to one lymph node per section, from the colon-draining dMLN (section 1, red) to the proximal LN (section 6). Data was normalized to the subset frequency in the dMLN (MLN1) (expt. = 2, n = 3). (<bold>D</bold>) There is comparable T cell activation by all subsets of migratory cDCs. T cell activation potential of migratory cDC subsets was quantified by coculturing cDCs with naïve OT-II T cells as in <xref ref-type="fig" rid="fig1">Figure 1A</xref> as well as indicated concentrations of OVA<sup>323-339</sup> peptide (expt. = 5). Each dot represents an individual mouse (<bold>A</bold>) or the mean of indicated experiments (<bold>C and D</bold>). Mean ± SEM (<bold>A, C, and D</bold>) shown. p-values from Tukey’s multiple comparisons tests (<bold>A</bold>); two-way repeated measures ANOVA of cDC subset (<bold>C</bold>); mixed effects analysis of repeated measures of cDC subset with Tukey’s multiple comparisons tests (<bold>D</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. The following source data are available for (<bold>A and B</bold>): <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref> (<bold>C</bold>) and <xref ref-type="supplementary-material" rid="fig2s1sdata2">Figure 2—figure supplement 1—source data 2</xref> (<bold>D</bold>).</p><p> <supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Migratory cDC1s are increased in the dMLN of wild-type mice relative to the proximal MLN (pMLN), <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref> raw data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54792-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Comparable T cell activation by all subsets of migratory conventional dendritic cells (cDCs), <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref> raw data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54792-fig2-figsupp1-data2-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>cDC1s are not required for Helicobacter-specific pTreg cell differentiation in vivo</title><p>We next used mice genetically deficient in cDC subsets to study pTreg cell differentiation in vivo. Based on prior studies showing the importance of cDC1s in oral tolerance (<xref ref-type="bibr" rid="bib22">Esterházy et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Mazzini et al., 2014</xref>), we previously studied cDC1-deficient <italic>Batf3</italic><sup>–/–</sup> mice (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). We found that CT2 and CT6 pTreg cell development were unchanged in <italic>Batf3<sup>–/–</sup></italic> mice, consistent with studies examining DTH responses after OVA enema (<xref ref-type="bibr" rid="bib76">Veenbergen et al., 2016</xref>). However, one caveat of <italic>Batf3</italic><sup>–/–</sup> mice is that a large number of cDC1s remain in mucosal tissue and specifically in the dMLN due to the compensatory expression of <italic>Batf</italic> in a pro-inflammatory environment (<xref ref-type="bibr" rid="bib73">Tussiwand et al., 2012</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). It was therefore possible that cDC1s in <italic>Batf3</italic><sup>–/–</sup> mice were sufficient to maintain pTreg cell selection.</p><p>In comparison to <italic>Batf3</italic><sup>–/–</sup> mice, mice which have a 149 bp deletion in the <italic>Irf8</italic> enhancer including the +32 kb BATF3-binding enhancer element (<italic>Irf8<sup>Δ149en/Δ149en</sup></italic>, formerly <italic>Irf8</italic> +32 5’<sup>–/–</sup><xref ref-type="bibr" rid="bib20">Durai et al., 2019</xref>) showed a much greater reduction of the number of cDC1s in the dMLN (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice did not have a decrease in total migratory cDC numbers, as there were increased numbers of CD103<sup>+</sup> CD11b<sup>+</sup> and to a lesser extent CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s in the absence of cDC1s (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The frequency of polyclonal colonic CD4<sup>+</sup> FOXP3<sup>+</sup> T cells was unchanged in <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Additionally, the proportion of colonic pTreg cells marked by low HELIOS expression (<xref ref-type="bibr" rid="bib71">Thornton et al., 2010</xref>) was unchanged in <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Although low HELIOS expression is an imperfect marker for pTreg cells, these data suggest that the proportion of bacteria-specific Treg cells is not grossly altered by the loss of CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s. Finally, both FOXP3<sup>–</sup> and FOXP3<sup>+</sup> colonic polyclonal T cells exhibited significant decreases in TBET (<italic>Tbx21</italic>) expression, confirming that cDC1s are important for the induction of Th1 and TBET<sup>+</sup> Treg cells (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Conventional T cells showed increased GATA3 expression, suggesting that compensatory Th2 development occurs with the loss of cDC1s and decrease in Th1 development (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). RORγt (<italic>Rorc</italic>) expression in colonic conventional T cells remained low after the loss of cDC1s. Together, these data suggest that loss of cDC1s selectively increases colonic Th2 frequencies at the expense of Th1 cells, while polyclonal peripheral FOXP3<sup>+</sup> Treg cell proportions are maintained.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s are not required for Helicobacter-specific peripheral regulatory T (pTreg) differentiation in vivo.</title><p>(<bold>A</bold>) Deficiency of CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s in the distal mesenteric lymph node (dMLN) of <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. Representative fluorescence-activated cell sorting (FACS) plot and quantification of migratory conventional dendritic cell (cDC) subsets in the dMLN of littermate <italic>Irf8<sup>+/Δ149en</sup></italic> and <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (expt. = 3, n = 9–11). (<bold>B</bold>) Decreased frequency of Th1 and TBET<sup>+</sup> Treg cells in the colon lamina propria (cLP) of <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. Representative FACS plots and intracellular staining quantification of FOXP3, HELIOS, TBET, RORγt, and GATA3 expression in cLP are shown (expt. = 2). (<bold>C and D</bold>) Helicobacter-specific T cell activation and Treg cell differentiation are not dramatically altered in cDC1-deficient mice. Congenically marked 5 × 10<sup>4</sup> naïve CT2 (<bold>C</bold>) or 10<sup>5</sup> naïve CT6 (<bold>D</bold>) were transferred into littermate <italic>Irf8<sup>+/Δ149en</sup></italic> and <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice and analyzed for <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> expression and cell trace violet (CTV) dilution in the dMLN after 7 days (expt. = 3 each). (<bold>E</bold>) T cell activation and Treg cell differentiation in oral tolerance are not altered by loss of cDC1s. 5 × 10<sup>4</sup> naïve OT-II cells were transferred into littermate <italic>Irf8<sup>+/Δ149en</sup></italic> and <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice, which were gavaged with 50 mg OVA on consecutive days and analyzed as in (<bold>C and D</bold>) (expt. = 5). Each dot represents an individual mouse. Mean ± SEM (<bold>A–E</bold>) or + SEM (<bold>A</bold>, right) shown. p-values from Sidak’s multiple comparisons test (<bold>A</bold>, middle), two-way ANOVA subset/genotype interaction (<bold>A</bold>, right); Student’s t-test (<bold>B</bold>, middle), Sidak’s multiple comparisons test (<bold>B</bold>, right); Student’s t-test (<bold>C–E</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. The following figure supplement is available for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. The following source data are available for (<bold>A–E</bold>): <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref> (<bold>A</bold>, right).</p><p> <supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Deficiency of CD103<sup>+</sup> CD11b<sup>– </sup>cDC1s in the distal mesenteric lymph node (dMLN) of <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice, <xref ref-type="fig" rid="fig3">Figure 3A</xref> raw data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54792-fig3-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s are not required for Helicobacter-specific peripheral regulatory T (pTreg) differentiation in vivo.</title><p>(<bold>A</bold>) Frequency, but not number, of CD103<sup>+ </sup>cDC1s are reduced in the distal mesenteric lymph node (dMLN) of <italic>Batf3<sup>–/–</sup></italic> mice. Representative fluorescence-activated cell sorting (FACS) plots and quantification of migratory conventional dendritic cell (cDC) subsets in the dMLN of littermate <italic>Batf3<sup>+/–</sup></italic> and <italic>Batf3<sup>–/–</sup></italic> mice (expt. = 2, n = 2). (<bold>B</bold>) Deficiency of CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s in the proximal MLN (pMLN) of <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. Representative FACS plot and quantification of migratory cDC subsets in the pMLN of littermate <italic>Irf8<sup>+/Δ149en</sup></italic> and <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (expt. = 3). Each dot represents an individual mouse. Mean ± SEM (<bold>A and B</bold>) or + SEM (<bold>A</bold>, right) shown. p-values from Sidak’s multiple comparisons test (<bold>B</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. The following source data are available for (<bold>A and B</bold>): <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref> (<bold>A</bold>, right).</p><p> <supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Frequency, but not number, of CD103<sup>+</sup> cDC1s are reduced in the distal mesenteric lymph node (dMLN) of <italic>Batf3<sup>–/–</sup> </italic>mice, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref> raw data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54792-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig3-figsupp1-v2.tif"/></fig></fig-group><p>To assess the effects of cDC1 loss on commensal antigen-specific pTreg cell development, we transferred naive CT2 and CT6 cells into 3–4-week-old <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. We used 3–4-week-old recipient mice throughout our work to model the natural timeframe of pTreg induction to commensal bacteria as well as food exposure, which occurs at weaning (<xref ref-type="bibr" rid="bib3">Atarashi et al., 2011</xref>; <xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). Moreover, we previously found that CT2 and CT6 pTreg cell differentiation decreases in mice greater than 5 weeks of age (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). After such transfer, both CT2 and CT6 exhibited small decreases in pTreg cell differentiation in <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice, but this was not proportional to the loss of cDC1s (<xref ref-type="fig" rid="fig3">Figure 3C,D</xref>). The loss of cDC1s had a differential effect on CT2 and CT6 antigen recognition and activation, as CT2 showed decreased, and CT6 showed increased, cell trace violet (CTV) dilution in <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3C,D</xref>). Under these conditions, CTV dilution in CT2 and CT6 is entirely dependent on Helicobacter – see Figure 4A in <xref ref-type="bibr" rid="bib15">Chai et al., 2017</xref>. Thus, cDC1s may be more involved in <italic>H. typhlonius</italic> antigen presentation to CT2 than <italic>H. apodemus</italic> presentation to CT6, but they are not essential for Helicobacter-specific pTreg cell differentiation. Furthermore, the selective expansion of DP cDC2s in <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice and the increase in CTV dilution particularly in Foxp3<sup>–</sup> CT6 cells may indicate that DP cDC2s are more capable of antigen presentation to naïve CT6 cells than CT2 cells, and that this expansion of DP cDC2s is detrimental to CT6 pTreg cell differentiation.</p><p>Since it had previously been reported that Treg cell differentiation was diminished in <italic>Zbtb46</italic><sup>Cre</sup>::<italic>Irf8</italic><sup>fl/fl</sup> mice in a model of oral tolerance (<xref ref-type="bibr" rid="bib22">Esterházy et al., 2016</xref>), we asked whether this was also true for <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. Similar to the dMLN, CD103<sup>+</sup> SP cDC1s were significantly reduced with a compensatory increase in the CD103<sup>+</sup> CD11b<sup>+</sup> DP cDC2 population in the proximal MLN (pMLN: all MLN except for dMLN) of <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). To assess pTreg differentiation in response to oral antigens, we transferred OT-II T cells into OVA-gavaged 3–4-week-old mice to maintain consistency with the CT2/CT6 transfer experiments, which are affected by host age (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>), as well as to model oral antigen exposure that takes place at weaning. In contrast to a prior study (<xref ref-type="bibr" rid="bib22">Esterházy et al., 2016</xref>), we did not see a change in the frequency of whole MLN Foxp3<sup>+</sup> cells among transferred naïve OT-II cells in <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> vs <italic>Irf8<sup>+/Δ149en</sup></italic> mice fed OVA (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). We did observe a trend toward decreased T cell activation in <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice as measured by CTV dilution, similar to what we saw for CT2 (<xref ref-type="fig" rid="fig3">Figure 3C,E</xref>). The difference between this and the previous study could be due to the use of younger vs older 7–12-week-old hosts (<xref ref-type="bibr" rid="bib22">Esterházy et al., 2016</xref>), or to the nature of the <italic>Irf8</italic> gene locus modification in cDCs between the two mouse lines: <italic>Zbtb46</italic><sup>Cre</sup>::<italic>Irf8</italic><sup>fl/fl</sup> mice lack IRF8 expression in all cDCs (but with incomplete penetrance), while <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice lack IRF8 expression only in BATF3-dependent cDC1s (<xref ref-type="bibr" rid="bib20">Durai et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Loschko et al., 2016</xref>). In summary, our data suggest that cDC1s can contribute to the antigen presentation of oral as well as bacterial antigens but are not required for pTreg cell differentiation to those antigens.</p></sec><sec id="s2-4"><title>CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s are not required for Helicobacter-specific pTreg cell differentiation in vivo</title><p>We next asked whether the CD103<sup>+</sup> CD11b<sup>+</sup> (DP) cDC2 subset is required for Helicobacter-specific pTreg cell differentiation, as our in vitro data showed that CT2 and CT6 are most efficiently activated by this subset (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Others have shown that this subset is preferentially diverted from the lymphatics to the mesenteric fat after <italic>Yersinia pseudotuberculosis</italic> infection, altering the induction of tolerance to commensal microbiota (<xref ref-type="bibr" rid="bib26">Fonseca et al., 2015</xref>). We previously showed that loss of this subset in Notch2-ΔDC mice results in decreased in vivo CT2 and CT6 pTreg cell differentiation (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). To confirm these results in another model of DP cDC2 deletion, we transferred naïve CT2 and CT6 T cells into Itgax-Cre::<italic>Irf4<sup>fl/fl</sup></italic> (Irf4-ΔDC) mice, which exhibit significantly reduced DP cDC2s in the dMLN (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib58">Persson et al., 2013</xref>). Similar to Notch2-ΔDC mice, CT2 Foxp3<sup>–</sup> cells trended toward increased antigen stimulation as measured by CTV dilution (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>; <xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). However, CT2 and CT6 pTreg cell development were unchanged in Irf4-ΔDC mice in contrast to Notch2-ΔDC mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B,C</xref>). This discrepancy suggests that the effects of these genetic modifications on pTreg cell generation were not related to the loss of DP cDC2s, which occurred in both Notch2-ΔDC and Irf4-ΔDC mice, but rather to differences arising from deletion of these genes in the remaining cDCs. We therefore turned to a third genetic model of DP cDC2 depletion that does not require Itgax-Cre mediated gene deletion in all cDCs, but instead uses diphtheria toxin driven by the human langerin promoter (CD207-DTA; formerly huLangerin-DTA) (<xref ref-type="bibr" rid="bib78">Welty et al., 2013</xref>).</p><p>We first confirmed that DP cDC2s are missing in the dMLN in CD207-DTA mice, as it was previously only reported for the whole MLN (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; <xref ref-type="bibr" rid="bib78">Welty et al., 2013</xref>). Since the reduction in cDC2s in CD207-DTA mice can be difficult to appreciate due to spillage of single positive cells into the DP gate, we used additional markers to more specifically quantify DP cDC2s in CD207-DTA mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). In the SIRPα<sup>+</sup> cDC2 population, DP cells were markedly reduced in CD207-DTA mice. Similarly, SIRPα<sup>+</sup> cDC2s with CD101 expression, which in combination with CD103<sup>+</sup> is a marker for DP cells (<xref ref-type="bibr" rid="bib4">Bain et al., 2017</xref>), were also significantly reduced in CD207-DTA mice.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s are not necessary for in vivo Helicobacter-specific peripheral regulatory T (pTreg) differentiation.</title><p>(<bold>A</bold>) Double positive CD103<sup>+</sup> CD11b<sup>+</sup> (DP) cDC2s are lost in the distal mesenteric lymph node (dMLN) of CD207-DTA mice. Representative fluorescence-activated cell sorting (FACS) plot and quantification of migratory conventional dendritic cell (cDC) subsets in the dMLN of littermate control (WT, <italic>Batf3<sup>+/–</sup></italic>, or <italic>Irf8<sup>+/Δ149en</sup></italic> mice) and CD207-DTA mice (expt. = 7, n = 10). (<bold>B</bold>) The frequencies of T cell subsets in the colon lamina propria (cLP) are unchanged in CD207-DTA mice. Representative FACS plots and intracellular staining quantification of FOXP3, HELIOS, TBET, RORγt, and GATA3 expression in cLP are shown (expt. = 3). (<bold>C and D</bold>) Helicobacter-specific T cell activation and Treg cell differentiation are not altered in DP cDC2-deficient mice. Congenically-marked 5 × 10<sup>4</sup> naïve CT2 (<bold>C</bold>) or 10<sup>5</sup> naïve CT6 (<bold>D</bold>) were transferred into littermate control and CD207-DTA mice and analyzed for <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> expression and cell trace violet (CTV) dilution in the dMLN after 7 days (expt. = 8, 7, respectively). (<bold>E</bold>) Treg cell differentiation in oral tolerance is increased with the loss of DP cDC2s. 5 × 10<sup>4</sup> naïve OT-II cells were transferred into littermate WT and CD207-DTA mice, which were gavaged with 50 mg OVA on consecutive days and analyzed as in (<bold>C and D</bold>) (expt. = 5). Each dot represents an individual mouse. Mean ± SEM (<bold>A–E</bold>) or + SEM (<bold>A</bold>, right). p-values from Sidak’s multiple comparisons test (<bold>A</bold>, middle), two-way ANOVA subset/genotype interaction (<bold>A</bold>, right); Student’s t-test (<bold>B</bold>, middle), Sidak’s multiple comparisons test (<bold>B</bold>, right); Student’s t-test (<bold>C–E</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. The following figure supplement is available for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>. The following source data are available for (<bold>A–E</bold>): <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref> (<bold>A</bold>, right).</p><p> <supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Double positive CD103<sup>+</sup> CD11b<sup>+</sup> (DP) cDC2s are lost in the distal mesenteric lymph node (dMLN) of CD207-DTA mice, <xref ref-type="fig" rid="fig4">Figure 4A</xref> raw data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54792-fig4-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s are not necessary for in vivo Helicobacter-specific peripheral regulatory T (pTreg) differentiation.</title><p>(<bold>A</bold>) Double positive CD103<sup>+</sup> CD11b<sup>+</sup> (DP) cDC2s are lost in the distal mesenteric lymph node (dMLN) of Irf4-ΔDC mice.</p><p>Representative fluorescence-activated cell sorting (FACS) plots and quantification of migratory conventional dendritic cell (cDC) subsets in the dMLN of littermate control (<italic>Irf4</italic><sup>fl/fl</sup> or <italic>Irf4</italic><sup>–/fl</sup>) and Irf4-ΔDC mice (expt. = 2). (<bold>B and C</bold>) CT2 and CT6 peripheral regulatory T (pTreg) cell differentiation is unaffected in Irf4-ΔDC mice. Congenically marked 5 × 10<sup>4</sup> naïve CT2 (<bold>B</bold>) or 10<sup>5</sup> naïve CT6 (<bold>C</bold>) were transferred into littermate <italic>Irf4</italic><sup>fl/fl</sup>, <italic>Irf4</italic><sup>–/fl</sup>, and Irf4-ΔDC mice and analyzed for <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> expression and cell trace violet (CTV) dilution in the dMLN after 7 days (expt. = 3, except for CT6 CTV where expt. = 2). (<bold>D</bold>) Analysis of additional cDC markers shows that DP cDC2s are lost in CD207-DTA mice. Representative FACS plots and quantification of CD103<sup>+</sup> CD11b<sup>+</sup> and CD103<sup>+</sup> CD101<sup>+</sup> SIRPα<sup>+</sup> cDC2s in the dMLN of littermate control and CD207-DTA mice (expt. = 1). (<bold>E</bold>) Deficiency of CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s in the proximal MLN (pMLN) of CD207-DTA mice. Representative FACS plot and quantification of migratory cDC subsets in the pMLN of littermate control and CD207-DTA mice (expt. = 3). Each dot represents an individual mouse. Mean ± SEM shown. p-values from Student’s t-test (<bold>B and C</bold>) or Sidak’s multiple comparisons test (<bold>D and E</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig4-figsupp1-v2.tif"/></fig></fig-group><p>Analysis of polyclonal colon T cells in CD207-DTA mice revealed that there was neither a significant increase in Treg cells nor the proportion of HELIOS<sup>lo</sup> putative pTreg cells (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). In contrast to previous reports showing that CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s are important for Th17 differentiation in the small intestine lamina propria (<xref ref-type="bibr" rid="bib58">Persson et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Welty et al., 2013</xref>), CD207-DTA mice did not show a decreased percentage of polyclonal Th17 cells or RORγt<sup>+</sup> Treg cells in the cLP, the former of which was low at homeostasis (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Additionally, the expression of other T cell lineage transcription factors in both FOXP3<sup>–</sup> and FOXP3<sup>+</sup> T cells were unchanged in colonic polyclonal T cells of CD207-DTA mice (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). These data suggest that CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s, which constitute a small proportion of cDCs within colon-associated dMLN, are not required for colonic T cell differentiation/maintenance at homeostasis.</p><p>When naïve CT2 and CT6 T cells were transferred into CD207-DTA mice, they differentiated into Treg cells normally (<xref ref-type="fig" rid="fig4">Figure 4C,D</xref>). In addition, T cell activation of both Foxp3<sup>–</sup> and Foxp3<sup>+</sup> CT2 and CT6 were unchanged in CD207-DTA mice, as measured by CTV dilution (<xref ref-type="fig" rid="fig4">Figure 4C,D</xref>). Since DP cDC2s constitute a small percentage of cDCs in the dMLN but a much greater percentage in the pMLN, we wondered whether loss of these cells would have a greater effect on Treg cell development in the small-intestine-draining MLN (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). As expected, CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s were reduced in the pMLN of CD207-DTA mice, with a compensatory increase in the frequency of CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>). We therefore examined Treg cell development in oral tolerance after OVA feeding. Surprisingly, given that others have reported a critical role for CD103<sup>+</sup> CD11b<sup>+</sup> DP cDCs in oral tolerance Treg cell development (<xref ref-type="bibr" rid="bib48">Mazzini et al., 2014</xref>), OT-II pTreg cell differentiation was significantly increased in CD207-DTA mice without changing T cell activation, indicating that loss of DP cDC2s enhances pTreg cell differentiation in oral tolerance (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). In summary, these data suggest that DP cDC2s are not required for Helicobacter- or OVA-specific Treg cell generation in the MLN.</p></sec><sec id="s2-5"><title>Decreased CD103<sup>+</sup> cDC1 and cDC2 cell number does not impact Helicobacter-specific pTreg cell differentiation in vivo</title><p>At least one study suggested that CD103<sup>+</sup> cDCs collectively, encompassing both cDC1s and DP cDC2s, are responsible for in vivo Treg cell generation/maintenance in the small intestine (<xref ref-type="bibr" rid="bib78">Welty et al., 2013</xref>). This study utilized CD207-DTA::<italic>Batf3</italic><sup>–/–</sup>mice to delete CD103<sup>+</sup> cDCs. However, as in <italic>Batf3<sup>–/–</sup></italic> mice, we have observed that a substantial number of cDC1s can sometimes remain in CD207-DTA::<italic>Batf3<sup>–/–</sup></italic> mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). When naïve CT2 and CT6 T cells were transferred into CD207-DTA::<italic>Batf3<sup>–/–</sup></italic> mice, they showed no decrease in pTreg cell differentiation (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B,C</xref>). Both CT2 and CT6 showed decreased T cell activation as measured by CTV dilution (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B,C</xref>). Thus, partial deletion of CD103<sup>+</sup> cDCs resulted in decreased Helicobacter antigen presentation without affecting pTreg cell differentiation.</p><p>To more efficiently delete CD103<sup>+</sup> cDCs in the dMLN, we bred <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice to CD207-DTA mice. Unlike straight <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice, CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice did not have a large increase in DP cDC2s when cDC1 generation was blocked (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Some CD103<sup>+</sup> cDC1s and cDC2s remained in the dMLN of these mice, presumably due to compensatory cDC development/survival when a large fraction of cDCs are deleted (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Remaining cDC1s expressed canonical cDC1 makers such as XCR1 and CD36 and thus seem to be bona-fide cDC1s (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). cLP polyclonal Treg cell frequencies as well as the proportion of putative commensal-specific HELIOS<sup>lo</sup> Treg cells were unchanged in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice, indicating that substantial loss of CD103<sup>+</sup> cDC1s and cDC2s does not broadly affect Treg cell development (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). In contrast to <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice did not show significant decreases in Th1 and TBET<sup>+</sup> Treg cells and only a minor, non-significant, increase in colonic GATA3<sup>+</sup> Th2 cells (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), suggesting that effects of cDC1-deficiency on Teff cell generation may be offset by the loss of DP cDC2s.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s are sufficient for in vivo Helicobacter-specific peripheral regulatory T (pTreg) differentiation.</title><p>(<bold>A</bold>) CD103<sup>+</sup> cDC1s and cDC2s are greatly reduced in the distal mesenteric lymph node (dMLN) of CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. Representative fluorescence-activated cell sorting (FACS) plot and quantification of migratory conventional dendritic cell (cDC) subsets in the dMLN of littermate <italic>Irf8<sup>+/Δ149en</sup></italic> and CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (expt. = 7, n = 7). (<bold>B</bold>) The frequency of polyclonal pTreg cells is unchanged in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice, but Th1 and TBET<sup>+</sup> Treg cells are decreased. Representative FACS plots and intracellular staining quantification of FOXP3, HELIOS, TBET, RORγt, and GATA3 expression in colon lamina propria (expt. = 3–4). (<bold>C and D</bold>) Helicobacter-specific T cell activation and Treg cell differentiation are not dramatically altered in CD103<sup>+</sup> cDC1 and cDC2-deficient mice. Congenically marked 5 × 10<sup>4</sup> naïve CT2 (<bold>C</bold>) or 10<sup>5</sup> naïve CT6 (<bold>D</bold>) were transferred into littermate <italic>Irf8<sup>+/Δ149en</sup></italic> and CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice and analyzed for <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> expression and cell trace violet (CTV) dilution in the dMLN after 7 days (expt. = 4 for both). (<bold>E</bold>) CT6 pTreg cell differentiation is inversely correlated with the number of CD103<sup>+</sup> cDC1s and cDC2s in the dMLN. Congenically marked 5 × 10<sup>4</sup> naïve CT2 (left) or 10<sup>5</sup> naïve CT6 (right) were transferred into littermate control, CD207-DTA, and CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice and analyzed after 7 days. CT2 and CT6 <italic>Foxp3<sup>I</sup></italic><sup>RES-GFP or Thy1.1</sup> expression was compared to cDC subset numbers in the same dMLNs (expt. = 2). Each dot represents an individual mouse. Mean ± SEM (<bold>A–D</bold>) or + SEM (<bold>A</bold>, right). p-values from Sidak’s multiple comparisons test (<bold>A</bold>, middle), two-way ANOVA subset/genotype interaction (<bold>A</bold>, right); Student’s t-test (<bold>B</bold>, middle), Sidak’s multiple comparisons test (<bold>B</bold>, right); Student’s t-test (<bold>C and D</bold>); R<sup>2</sup> and p-value for nonzero slope (<bold>E</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. The following figure supplements are available for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</p><p> <supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>CD103<sup>+</sup> cDC1s and cDC2s are greatly reduced in the distal mesenteric lymph node (dMLN) of CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup> </italic>mice, <xref ref-type="fig" rid="fig5">Figure 5A</xref> raw data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54792-fig5-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>CD103<sup>– </sup>CD11b<sup>+ </sup>cDC2s are sufficient for in vivoHelicobacter-specific peripheral regulatory T (pTreg) differentiation.</title><p>(<bold>A</bold>) Variable frequencies of CD103<sup>+ </sup>conventional dendritic cells (cDCs) in the distal mesenteric lymph node (dMLN) of CD207-DTA::<italic>Batf3<sup>–/–</sup></italic> mice. Fluorescence-activated cell sorting (FACS) plot and quantification of migratory cDC subsets in the dMLN of littermate <italic>Batf3<sup>+/–</sup></italic> and CD207-DTA::<italic>Batf3<sup>–/–</sup></italic> mice (expt. = 2, n = 2). (<bold>B and C</bold>) Helicobacter-specific Treg cell differentiation is not dramatically altered in CD207-DTA::<italic>Batf3<sup>–/–</sup></italic> mice, although T cell activation is slightly reduced. Congenically marked 5 × 10<sup>4</sup> naïve CT2 (<bold>B</bold>) or 10<sup>5</sup> naïve CT6 (<bold>C</bold>) were transferred into littermate <italic>Batf3</italic><sup>+/–</sup> and CD207-DTA::<italic>Batf3</italic><sup>–/–</sup> mice and analyzed for <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> expression and cell trace violet (CTV) dilution in the dMLN after 7 days (expt. = 2 [<bold>B</bold>], expt. = 5 [<bold>C</bold>]). (<bold>D</bold>) Residual CD103<sup>+</sup> CD11b<sup>–</sup> cells in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> express markers of cDC1s. Representative FACS plots and quantification of the cDC1 markers CD36 and XCR1 in the CD103<sup>+</sup> CD11b<sup>–</sup> population in <italic>Irf8<sup>+/Δ149en</sup></italic> and CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (expt. = 2). Each dot represents an individual mouse. Mean ± SEM (<bold>A–D</bold>) or + SEM (<bold>A</bold>, right). p-values from Student’s t-test (<bold>B–D</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p> <supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Variable frequencies of CD103<sup>+ </sup>conventional dendritic cells (cDCs) in the distal mesenteric lymph node (dMLN) of CD207-DTA::<italic>Batf3<sup>–/–</sup></italic>mice, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref> raw data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54792-fig5-figsupp1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>CD103<sup>– </sup>CD11b<sup>+ </sup>cDC2s are sufficient for in vivo Helicobacter-specific peripheral regulatory T (pTreg) differentiation.</title><p>(<bold>A and B</bold>) Helicobacter-specific T cell activation and Treg cell differentiation are not dramatically altered in the cLP of CD103<sup>+</sup> cDC1 and cDC2-deficient mice. Congenically marked 5 × 10<sup>4</sup> naïve CT2 (<bold>A</bold>) or 10<sup>5</sup> naïve CT6 (<bold>B</bold>) were transferred into littermate <italic>Irf8<sup>+/Δ149en</sup></italic> and CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice and analyzed for <italic>Foxp3<sup>I</sup></italic><sup>RES-GFP or Thy1.1</sup> expression and cell trace violet (CTV) dilution in the cLP after 7 days (expt. = 4 [<bold>A</bold>]; expt. = 3 [<bold>B</bold>]). (<bold>C</bold>) CT6 peripheral regulatory T (pTreg) cell differentiation is inversely correlated with the frequency/number of CD103<sup>+</sup> SP cDC1s in the distal mesenteric lymph node (dMLN). Congenically marked 5 × 10<sup>4</sup> naïve CT2 or 10<sup>5</sup> naïve CT6 were transferred into littermate control, CD207-DTA, and CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice and analyzed after 7 days. CT2 and CT6 <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> expression were compared to conventional dendritic cell (cDC) subset numbers and frequencies in the same dMLNs (expt. = 2). Each dot represents an individual mouse. Mean ± SEM shown (<bold>A and B</bold>). p-values from Student’s t-test (<bold>A and B</bold>); R<sup>2</sup> and p-value for nonzero slope (<bold>C</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig5-figsupp2-v2.tif"/></fig></fig-group><p>When we transferred CT2 and CT6 into CD207-DTA::<italic>Irf8<sup>Δ149en/ Δ149en</sup></italic> mice to assess the antigen-specific contribution of CD103<sup>+</sup> cDC1s and cDC2s to pTreg cell development, we observed no decreases in Helicobacter-specific pTreg cells (<xref ref-type="fig" rid="fig5">Figure 5C,D</xref>). Both Foxp3<sup>–</sup> CT2 and CT6 showed decreased cell activation by CTV dilution in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice, in contrast to the increased cell activation seen in Foxp3<sup>–</sup> CT6 cells in <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig5">Figure 5C,D</xref>). To determine if pTreg cell differentiation of CT2 and CT6 in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice was conserved after trafficking to peripheral tissues, we analyzed CT2 and CT6 cells recovered from the cLP 7 days after naïve T cell transfer. Similar to the dMLN, CT2 and CT6 pTreg cell differentiation were not decreased while Foxp3<sup>–</sup> cells showed trends of decreased antigen stimulation based on CTV dilution (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A,B</xref>). As CD103<sup>+</sup> cDC1s and cDC2s in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice were not completely absent, we wondered whether CT2 and CT6 pTreg cell differentiation correlated with the loss of cDC subsets in the dMLN. Notably, the loss of CD103<sup>+</sup> cDCs (cDC1 and/or DP) did not significantly correlate with decreases in pTreg cell induction (<xref ref-type="fig" rid="fig5">Figure 5E</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C</xref>). Rather, we saw an increase in the percent of Foxp3<sup>+</sup> CT6 cells with decreased CD103<sup>+</sup> DC1s, which trended similarly for CT2. Thus, decreased antigen presentation capability with decreased CD103<sup>+</sup> cDC1s and cDC2s in vivo did not significantly impact Helicobacter<italic>-</italic>specific pTreg cell differentiation. However, the maintenance of some CD103<sup>+</sup> cDC1s and cDC2 in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice represents a caveat to the interpretation of the in vivo data presented here.</p></sec><sec id="s2-6"><title>Loss of cDC subsets does not markedly alter the colon bacterial microbiome</title><p>Perturbations of the microbiota due to cDC subset loss could affect antigen-specific pTreg cell differentiation (<xref ref-type="bibr" rid="bib8">Brown et al., 2019</xref>). We therefore performed 16S rRNA sequencing and amplicon sequence variant (ASV) analysis of colonic bacteria. Shannon alpha diversity was unchanged in the cDC-subset deficient mice (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). Additionally, NMDS analyses of bacterial community compositions by Bray–Curtis or UniFrac distances did not show obvious clustering by genotype (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>), consistent with a nonsignificant PERMANOVA analysis. Finally, the frequencies of <italic>H. typhlonius</italic> and <italic>H. apodemus</italic> ASVs were not markedly changed by cDC subset deficiency (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). While additional samples would likely improve power to detect differences in the microbiome due to cDC-subset deficiency, our data do not support the hypothesis that microbial changes affected Helicobacter-specific pTreg cell differentiation.</p></sec><sec id="s2-7"><title>Loss of CD103<sup>+</sup> cDC1s and cDC2s does not increase the tolerogenic potential of migratory CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s in vivo</title><p>Our data collectively suggest that pTreg cell induction is not confined to a single cDC subset and that migratory CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s are likely sufficient for Helicobacter-specific pTreg cell induction in vivo. However, it remained possible that after genetic deletion of CD103<sup>+</sup> cDC1s and cDC2s, the remaining CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s gain access to niches that facilitate their development into ‘tolerogenic’ cDCs. To assess this possibility, we quantified the expression of proteins and genes reported to be Treg cell-inducing (<xref ref-type="bibr" rid="bib17">Coombes et al., 2007</xref>; <xref ref-type="bibr" rid="bib29">Hasegawa and Matsumoto, 2018</xref>; <xref ref-type="bibr" rid="bib46">Marie et al., 2005</xref>; <xref ref-type="bibr" rid="bib52">Morris et al., 2003</xref>) in CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s from CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. T cell activation-associated proteins (MHC Class II (IAb), CD80, CD86, CD40, PD-L1, and PD-L2) were unchanged in CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s from CD207-DTA::<italic>Irf8<sup>Δ149en/ Δ149en</sup></italic> mice (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>). Additionally, the activity of RALDHs, of which RALDH2 in CD103<sup>+</sup> cDC1s and cDC2s has been shown to enhance pTreg cell generation in vitro (<xref ref-type="bibr" rid="bib17">Coombes et al., 2007</xref>; <xref ref-type="bibr" rid="bib66">Sun et al., 2007</xref>), was unchanged in CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s from CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Finally, genes (<italic>Tgfβ1–3</italic>, <italic>Itgb6</italic>, <italic>Itgb8</italic>) and proteins (TGFβ1, CD51) associated with TGF-β production and activation, a molecule that is critical for pTreg cell FOXP3 induction (<xref ref-type="bibr" rid="bib16">Chen et al., 2003</xref>), were not increased and for some genes (<italic>Tgfb2</italic> and <italic>Tgfb3</italic>) were decreased in CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s from CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (<xref ref-type="fig" rid="fig6">Figure 6B,C</xref>). The integrins αvβ6 and αvβ8 activate TGF-β, and αvβ8 expression in cDC1s has been specifically associated with tolerance in the intestines (<xref ref-type="bibr" rid="bib7">Boucard-Jourdin et al., 2016</xref>; <xref ref-type="bibr" rid="bib52">Morris et al., 2003</xref>; <xref ref-type="bibr" rid="bib72">Travis et al., 2007</xref>). While our data confirm previous studies showing preferential function of RALDH and expression of <italic>Itgb8</italic> in cDC1s (<xref ref-type="bibr" rid="bib7">Boucard-Jourdin et al., 2016</xref>; <xref ref-type="bibr" rid="bib17">Coombes et al., 2007</xref>; <xref ref-type="bibr" rid="bib66">Sun et al., 2007</xref>) and <italic>Ido1</italic> in CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s (<xref ref-type="bibr" rid="bib47">Matteoli et al., 2010</xref>), we found that other Treg cell inducing- and tolerance-associated genes and proteins such as CD51 (<italic>Itgav</italic>), <italic>Tgfb1</italic>, and <italic>Il10</italic> were preferentially expressed in CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s. However, the increased expression of <italic>Il10</italic>, <italic>Itgav</italic>, and <italic>Tgfb1</italic> may be due to the contamination of the CD103<sup>–</sup> CD11b<sup>+</sup> cDC2 subset by macrophages (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). These data therefore support the idea that each subset of cDCs may employ different mechanisms to induce pTreg cell development (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>). We also analyzed the remaining CD103<sup>+</sup> cDC1s and cDC2s in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice to determine if their expression of tolerogenic markers was altered. Remaining CD103<sup>+</sup> cDC1s and cDC2s showed significantly decreased CD86 expression and an increased trend of CD274 (PD-L1) expression, suggesting that they may be more ‘immature’ compared to their wild-type counterparts (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B</xref>). Taken together, these data suggest that pTreg cell selection in the context of CD103<sup>+</sup> cDC deletion is not due to ‘nurture’ of CD103<sup>–</sup> cDCs to become tolerogenic but suggests that the ‘nature’ of CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s in normal mice is to induce Helicobacter-specific pTreg cell differentiation.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>CD11b<sup>+</sup> SP cDC2s are tolerogenic by ‘nature’, not ‘nurture’.</title><p>(<bold>A</bold>) Retinal dehydrogenase (RALDH) activity as measured by Aldefluor is unchanged in CD11b<sup>+</sup> SP cDC2s in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice deficient in CD103<sup>+</sup> cDC1s and cDC2s (expt. = 2). (<bold>B</bold>) LAP and CD51 protein expression is unchanged in CD11b<sup>+</sup> SP cDC2s in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice (expt. = 2). (<bold>C</bold>) <italic>Tgfb1</italic>, <italic>IL10</italic>, <italic>Itgb6</italic>, <italic>Itgb8</italic>, and <italic>Ido1</italic> gene expression are unchanged in CD11b<sup>+</sup> SP cDC2s in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice, while <italic>Tgfb2</italic> and <italic>Tgfb3</italic> gene expression are decreased (expt. = 2). Each dot represents an individual mouse. Mean ± SEM shown (<bold>A–C</bold>). p-values from Tukey’s multiple comparisons test (<bold>A–C</bold>) using Δ-ΔCt values in (<bold>C</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>CD11b<sup>+ </sup>SP cDC2s are tolerogenic by ‘nature’, not ‘nurture’.</title><p>(<bold>A and B</bold>) The colonic bacterial microbiome is not significantly different among littermate control (<italic>Irf8<sup>+/Δ149en</sup></italic>), <italic>Irf8<sup>Δ149en/Δ149en</sup></italic>, CD207-DTA (<italic>Irf8<sup>+/+</sup></italic> and <italic>Irf8<sup>+/Δ149en</sup></italic>), and CD207-DTA:: <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. 16S rRNA sequencing was performed on whole colon lumen feces. Alpha diversity was analyzed by Shannon index (<bold>A</bold>) and beta diversity was analyzed by NMDS of Bray–Curtis and UniFrac distances using amplicon sequence variant (ASV) frequencies (<bold>B</bold>, top) (expt. = 4). Bacteria class abundance is plotted by stacked bar graph (<bold>B</bold>, bottom) (expt. = 4). (<bold>C</bold>) Frequencies of <italic>H. typhlonius</italic> and <italic>H. apodemus</italic> are not significantly different in littermate control, <italic>Irf8<sup>Δ149en/Δ149en</sup></italic>, CD207-DTA, and CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. 16S rRNA sequencing was performed as in (<bold>A</bold>) (expt. = 4). Each dot represents an individual mouse. Mean ± SEM shown (<bold>A and C</bold>). p-values from one-way ANOVA (<bold>A and C</bold>) with Dunnett’s multiple comparisons test (<bold>C</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p> <supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>16S rRNA sequencing of whole colon lumen feces of conventional dendritic cell (cDC)-deficient mice, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref> raw data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54792-fig6-figsupp1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>CD11b<sup>+ </sup>SP cDC2s are tolerogenic by ‘nature’, not ‘nurture’.</title><p>(<bold>A</bold>) Molecules involved in T cell activation are unchanged in CD11b<sup>+</sup> SP cDC2s in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. Representative expression of I-A<sup>b</sup>, CD80, CD86, CD40, CD273, and CD274 by flow cytometry is shown and quantified by median fluorescence intensity (MFI) (expt. = 2–3). (<bold>B</bold>) CD86 expression is decreased in remaining CD103<sup>+</sup> cDC1s and cDC2s in CD207-DTA::<italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice. Representative retinaldehyde dehydrogenase (RALDH) activity as measured by Aldefluor and expression of LAP, CD51, I-A<sup>b</sup>, CD80, CD86, CD40, CD273, and CD274 by flow cytometry are shown and quantified by MFI (expt. = 2–3). Each dot represents an individual mouse. Mean ± SEM shown. p-values from Tukey’s multiple comparisons test; *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig6-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-8"><title>Antigen dose-dependent superiority of CD103<sup>+</sup> cDC1s for in vitro pTreg cell selection</title><p>Our in vivo data are in marked contrast with previous in vitro studies (<xref ref-type="bibr" rid="bib17">Coombes et al., 2007</xref>; <xref ref-type="bibr" rid="bib66">Sun et al., 2007</xref>) regarding the importance of CD103<sup>+</sup> DCs, which in their study included both cDC1s and cDC2s. In vitro, DP cDC2s presenting Helicobacter antigens acquired in vivo were the most efficient at inducing Foxp3 in CT2 and CT6 T cells (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). However, the frequency of Foxp3<sup>+</sup> cells was much lower than that seen in the in vivo T cell transfer studies (<xref ref-type="fig" rid="fig3">Figures 3</xref>–<xref ref-type="fig" rid="fig5">5</xref>), The variance in Foxp3 induction ex vivo may be attributed to the level of antigen loaded in vivo, as Foxp3 upregulation was correlated with the extent of T cell stimulation by each cDC subset as assessed by the frequency of CD25<sup>+</sup> cells (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>).</p><p>To experimentally control the level of antigen presentation, we stimulated naïve OT-II T cells in vitro with varying concentrations of OVA peptide presented by sorted cDC subsets (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>, <xref ref-type="fig" rid="fig7">Figure 7A,B</xref>). Consistent with previous reports on the total CD103+ cDC population (<xref ref-type="bibr" rid="bib17">Coombes et al., 2007</xref>; <xref ref-type="bibr" rid="bib66">Sun et al., 2007</xref>), we found that CD103<sup>+</sup> SP cDC1s were the most efficient at inducing Foxp3 in naïve OT-II T cells in vitro (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). However, induction of Foxp3 varied according to TCR signal strength. At lower levels of TCR-stimulation with OVA peptide, all subsets of cDCs were able to induce Foxp3 equivalently, whereas CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s were more efficient at higher levels of antigen stimulation (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). This was also true if CD25 was used as a marker for T cell activation to control for possible differences in costimulation and MHC Class II levels between cDC subsets (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Whether these similarities or differences between cDC subsets observed in vitro reflect their ability to induce Foxp3 in vivo remains unclear. However, this in vitro assay does not appear to inform on pTreg cell selection to Helicobacter in vivo, perhaps due to uneven levels of antigen acquisition by each subset, reinforcing the need for in vivo studies of cDC subsets and pTreg cell selection.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Conventional dendritic cell (cDC)-mediated peripheral regulatory T (pTreg) cell differentiation in vivo is recessive to effector T cell development.</title><p>(<bold>A</bold>) Migratory cDC induction of OT-II pTreg cells in vitro is dependent on T cell receptor (TCR) stimulation. Treg cell induction of OT-II cells by migratory cDC subsets with varying concentrations of OVA<sup>323-339</sup> peptide is shown (expt. = 5). (<bold>B</bold>) In vitro, CD103<sup>+</sup> SP cDC1s have increased ability to induce OT-II pTreg cells at higher levels of TCR activation (based on CD25 upregulation). Migratory cDC subsets were cultured with naïve OT-II T cells as in (<bold>A</bold>) (expt. = 5). (<bold>C</bold>) TA1 cognate antigens are presented by mesenteric lymph node (MLN) migratory dendritic cells. 1.5 × 10<sup>3</sup> TA1- or CT6-expressing T cell hybrids were co-cultured in vitro with 5 × 10<sup>4</sup> ex vivo MLN migratory cDCs (MHCII<sup>hi</sup> CD11c<sup>int</sup>). NFAT-GFP expression in hybrids was analyzed after 40 hr (expt. = 2). (<bold>D</bold>) Expression of a Th1-inducing TCR (TA1) in CT6 cells dominantly inhibits CT6 pTreg cell differentiation in vivo. Naïve CT6 T cells were retrovirally transduced with either TA1 or a non-reactive control TCR (T7-2 or T9). Untransduced CT6, CT6 co-expressing TA1, or CT6 co-expressing T7-2 or T9 were transferred into each mouse; mice received either 5 × 10<sup>4</sup> of each TCR (closed shapes) or 2 × 10<sup>5</sup> of each TCR (open shapes). Expression of <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> and CXCR3 were quantified in the distal MLN (dMLN) after 7 days. Each dot represents the mean of indicated experiments (<bold>A and B</bold>), an individual co-culture well (<bold>C</bold>), or an individual mouse (<bold>D</bold>). Mean ± SEM shown (<bold>A–D</bold>). p-values from mixed effects analysis of repeated measures of DC subsets with Tukey’s multiple comparisons test (<bold>A and B</bold>); Tukey’s multiple comparisons test (<bold>C and D</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p> <supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Migratory conventional dendritic cell (cDC) induction of OT-II peripheral regulatory T (pTreg) cells in vitro is dependent on T cell receptor (TCR) stimulation, Figure 7A raw data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54792-fig7-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>In vitro, CD103<sup>+</sup> SP cDC1s have increased ability to induce OT-II peripheral regulatory T (pTreg) cells at higher levels of TCR activation, Figure 7B raw data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54792-fig7-data2-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Conventional dendritic cell (cDC)-mediated peripheral regulatory T (pTreg) cell differentiation in vivo is recessive to effector T cell development.</title><p>(<bold>A</bold>) Migratory conventional dendritic cell (cDC) subsets induce low levels of <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> in CT2 and CT6 in vitro. (<bold>B</bold>) The induction of <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> in CT2 and CT6 cultured with ex vivo migratory cDC subsets is correlated with the level of T cell receptor (TCR) stimulation by CD25 upregulation. For (<bold>A and B</bold>), each dot represents data from an individual experiment, in which sorted migratory cDC subsets from the pooled distal mesenteric lymph nodes (dMLNs) of 10–15 mice were cultured with naïve CT2 and CT6 T cells as in <xref ref-type="fig" rid="fig1">Figure 1A</xref> (expt. = 5–6). (<bold>C</bold>) In vitro Th1- or Th2-polarizing conditions inhibit in vivo pTreg cell differentiation of CT2 cells. 1.5 × 10<sup>5</sup> naïve CT2 T cells were activated and cultured in Th0, Th1, or Th2 conditions for 48 hr, transferred in vivo, and analyzed for <italic>Foxp3</italic><sup>IRES-GFP or Thy1.1</sup> upregulation in the dMLN after 2 weeks (expt. = 2). (<bold>D</bold>) TA1 TCR-expressing CT6 cells proliferate more than control TCR-expressing CT6 cells in vivo. 2 × 10<sup>5</sup> CT6 cells were transduced and transferred in vitro as in <xref ref-type="fig" rid="fig7">Figure 7D</xref>. Each dot represents an independent experiment. Mean ± SEM shown. p-value from one-way ANOVA (<bold>A</bold>); Linear regression with associated R<sup>2</sup> and p-value for nonzero slope (<bold>B</bold>); Tukey’s multiple comparisons test (<bold>C</bold>); Sidak’s multiple comparisons test (<bold>D</bold>); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54792-fig7-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-9"><title>A recessive model of pTreg cell selection</title><p>Our data do not support a model in which a single cDC subset is critical for inducing pTreg cell selection, and rather suggest that multiple cDC subsets are involved. However, the ability of multiple cDC subsets to induce FOXP3 may be problematic for responses to infection or injury. Evidence suggests that cDC subsets may have unique capacities to induce effector T cell subsets (<xref ref-type="bibr" rid="bib21">Durai and Murphy, 2016</xref>), supported by their different cytokine producing functions but also by their divergent abilities to sense specific bacterial components; for example, MLN CD103<sup>+</sup> CD11b<sup>–</sup> cDC1s have relatively high expression of <italic>Tlr9</italic> and CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s have relatively high expression of <italic>Tlr4</italic>, <italic>Tlr6</italic>, and <italic>Nod2</italic> (<xref ref-type="bibr" rid="bib22">Esterházy et al., 2016</xref>). CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s also express TLR5, which senses flagellin and is likely important for Teff cell responses to pathogenic bacteria such as Salmonella (<xref ref-type="bibr" rid="bib38">Kinnebrew et al., 2012</xref>; <xref ref-type="bibr" rid="bib75">Uematsu et al., 2008</xref>). We therefore hypothesized that pTreg cell selection is ‘recessive’, requiring all T cell-interacting antigen-presenting cDC subsets to be permissive to pTreg cell selection such that activated T cells at a minimum retain the ability to upregulate FOXP3. During inflammatory conditions, a subset of cDCs may then ‘dominantly’ induce fully differentiated effector T cells via the production of cytokines that block FOXP3 induction, even if the T cells subsequently encounter cDCs that facilitate pTreg cell generation.</p><p>To test this hypothesis, we used adoptive transfer of modified CT2 or CT6 T cells into wild-type, Helicobacter-colonized hosts, as the blockade of in vivo pTreg cell differentiation by Th1 differentiation has not been reported to our knowledge. First, we cultured naïve Helicobacter-specific cells in the presence of Th1- or Th2-polarizing conditions in vitro to model the possibility that pTreg cell differentiation in vivo would be dominantly inhibited by the presence of Th1- or Th2-inducing cytokines during activation. After activation in Th1 or Th2 conditions in vitro, in vivo pTreg cell differentiation of CT2 T cells was completely abrogated (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>). To address that in vitro activation itself did not lead to an inability to undergo pTreg cell differentiation in vivo, we cultured CT2 cells in ‘Th0’-inducing conditions, which permitted normal pTreg cell differentiation after adoptive transfer in vivo (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>). These data also show that in vitro T cell activation without the induction of Foxp3 (‘Th0’) does not result de facto in the generation of fully differentiated CD44<sup>hi</sup> effector T cells that are no longer capable of becoming pTreg cells, consistent with our previous observation that the frequency of Foxp3<sup>+</sup> cells continues to increase after 1 week in transferred transgenic T cells (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>).</p><p>To address the possibility that in vitro Th1 differentiation does not mimic in vivo conditions, we expressed a Th1-directing TCR (TA1) in CT6 T cells, hypothesizing that the TA1 TCR will engage antigen in a Th1 environment not normally experienced by CT6 cells under homeostatic conditions. We first confirmed that the stimulatory antigen for TA1, which is thus far uncharacterized, is presented by DCs in the MLN using T cell hybridoma cells expressing GFP under a minimal NFAT promoter (<xref ref-type="bibr" rid="bib35">Ise et al., 2010</xref>). When TA1- or CT6-expressing hybrids were co-cultured with MLN migratory DCs from Helicobacter-free mice, TA1 but not CT6-expressing hybrids were activated (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Looking then in vivo, CT6 cells that co-expressed TA1, but not a non-reactive control TCR, failed to induce Foxp3 but expressed the Th1 marker CXCR3 (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). CT6 cells that co-expressed TA1 also proliferated more than cells that expressed a non-reactive control TCR, indicating that CT6 engagement on a ‘tolerogenic’ cDC was not sufficient to inhibit cell division (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1D</xref>). Taken together, these data support a ‘recessive’ model in which pTreg cell differentiation is subdominant to a Th1 response in the same localized tissue environment.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The generation of gut commensal-specific pTreg cells is a critical mechanism for maintaining gut homeostasis, and yet the cDC subsets that present antigen to naïve T cells and direct T cell development remain unclear (<xref ref-type="bibr" rid="bib53">Mowat, 2018</xref>). Here, we provide direct evidence identifying the cDC subsets that are capable of presenting Helicobacter antigens. Unexpectedly, we found that all migratory cDC subsets, both CD103<sup>+</sup> and CD103<sup>–</sup>, contained cells capable of presenting Helicobacter antigens ex vivo. The use of genetic models with large reductions in specific cDC subsets supported the notion that CD103<sup>+</sup> cDC1s and cDC2s were neither required for antigen presentation nor pTreg cell generation in vivo. These observations argue against the notion that a singular tolerogenic cDC subsets presents gut antigens and induces pTreg cell generation (<xref ref-type="bibr" rid="bib29">Hasegawa and Matsumoto, 2018</xref>; <xref ref-type="bibr" rid="bib63">Scott et al., 2011</xref>; <xref ref-type="bibr" rid="bib67">Takenaka and Quintana, 2017</xref>; <xref ref-type="bibr" rid="bib68">Tanoue et al., 2016</xref>), and lend support to the idea that CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s are important or redundant for intestinal pTreg cell induction (<xref ref-type="bibr" rid="bib37">Kim et al., 2018</xref>; <xref ref-type="bibr" rid="bib76">Veenbergen et al., 2016</xref>). Our data also suggest a ‘recessive’ model in which all gut cDC subsets are permissive to pTreg cell generation during homeostasis, but where pTreg cell selection can be ‘dominantly’ blocked by the existence of pro-inflammatory cDCs during inflammation or infection, even when homeostatic pTreg cell inducing cDCs remain.</p><p>One issue with the study of intestinal cDC subsets in vivo is the limitation of the genetic tools used for cDC subset depletion. For example, <italic>Batf3<sup>–/–</sup></italic> mice have been used to deplete cDC1s, but many cDC1s remain in mucosal-associated tissues in these mice (<xref ref-type="bibr" rid="bib74">Tussiwand et al., 2015</xref>). Additionally, deletion of <italic>Batf3</italic> in other cell types may affect immune cell homeostasis beyond loss of cDC1 cells. Newer models such as the <italic>Xcr1</italic><sup>DTR</sup> mouse appears to be a more efficient alternative to <italic>Batf3</italic><sup>–/–</sup> mice for depletion of cDC1s (<xref ref-type="bibr" rid="bib80">Yamazaki et al., 2013</xref>). Similarly, <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice only lose IRF8 expression in cDC1 cells, resulting in specific loss of cDC1 development (<xref ref-type="bibr" rid="bib20">Durai et al., 2019</xref>). However, there may still be some limitations. <italic>Xcr1</italic><sup>DTR</sup> may not deplete immature cDC1s (5–10%) and may deplete a small fraction (5%) of CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s in the MLN (<xref ref-type="bibr" rid="bib80">Yamazaki et al., 2013</xref>). Also, longer term studies with diphtheria toxin are not possible due to the generation of neutralizing antibodies. Our data suggest that <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> also does not completely block cDC1 generation in the gut, specifically the colon. A direct experimental comparison of <italic>Xcr1</italic><sup>DTR</sup> and <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> is therefore needed. Nonetheless, we observed that the total number of cDC1s in <italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice was greatly reduced compared to control mice without grossly affecting Helicobacter-specific pTreg cell differentiation in vivo.</p><p>Similarly, the elimination of CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s has been achieved via Itgax-Cre mediated deletion of <italic>Irf4</italic> or <italic>Notch2</italic>, as well as CD207-DTA. However, we found the effects of these deletions on Helicobacter-specific pTreg cell generation varied substantially, with <italic>Irf4</italic> and CD207-DTA showing little to no effect and deletion of <italic>Notch2</italic> in cDCs inhibiting pTreg cell generation (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). Since all of these genetic models lead to a loss of DP cDC2s, our current interpretation of these discrepant effects is that DP cDC2s are not required for pTreg cell selection and that the deletion of <italic>Notch2</italic> in other cDC subsets leads directly or indirectly to a defect in pTreg cell induction. However, we acknowledge that CD207-DTA depletion of DP cDC2s is not complete in the context of cDC1 depletion, and that a caveat of these and other genetic models is that it remains possible that the remaining cDCs in the targeted subset may be sufficient for pTreg cell induction. Thus, these data provide a cautionary tale for studying cDC function using these Cre-deletion models that were originally used to analyze cDC development and suggest that new genetic models are required to better understand the role of DP and CD11b<sup>+</sup> SP cDC2 subsets in vivo.</p><p>An unexpected observation from our data was that all migratory cDC subsets presented Helicobacter antigens. Research into acquisition of luminal antigens by cDCs has suggested that specific cDC subsets may be specialized for this process. Small intestinal CD103<sup>+</sup> cDC1s or cDC2s have been reported to extend trans-epithelial dendrites into the intestinal lumen to phagocytose pathogenic <italic>Salmonella typhimurium</italic> during infection (<xref ref-type="bibr" rid="bib24">Farache et al., 2013</xref>). Goblet associated passages have been shown to deliver soluble dietary antigens to lamina propria CD103<sup>+</sup> cDC1s or cDC2s in the small intestine (<xref ref-type="bibr" rid="bib49">McDole et al., 2012</xref>). CD103<sup>+</sup> SP cDC1s have also been shown to be uniquely capable of cross-presenting antigens from apoptotic intestinal epithelial cells, which could contain phagocytosed luminal antigens (<xref ref-type="bibr" rid="bib14">Cerovic et al., 2015</xref>). Yet, to our knowledge, a direct assessment of the in vivo loaded endogenous commensal antigens presented by cDC subsets in the MLN has not been reported. Although our data shows that all cDC subsets acquire antigen, the loading may not be uniform, as we observed subtly different effects of cDC subset depletion on CT2 and CT6 T cell proliferation. This may be due to differences between <italic>H. typhlonius</italic> and <italic>H. apodemus</italic> colonization, or in the specific proteins recognized by CT2 and CT6. Future studies are required to determine if antigen loading on all cDC subsets is generalizable to other gut bacteria.</p><p>The lack of selectivity of Helicobacter antigens for presentation by a particular cDC subset, coupled with the in vivo observation that substantial deletion of CD103<sup>+</sup> cDC1s and cDC2s does not markedly impact pTreg cell selection to Helicobacter, favors the notion that Treg cell selection in vivo utilizes redundant cDC subsets rather than specialized ‘tolerogenic’ CD103<sup>+</sup> cDC1s and cDC2s. While these genetic models of cDC subset deficiency have clearly been shown to impact the immune system (<xref ref-type="bibr" rid="bib20">Durai et al., 2019</xref>; <xref ref-type="bibr" rid="bib78">Welty et al., 2013</xref>), we do acknowledge that the loss of CD103<sup>+</sup> cDC1s and cDC2s, while substantial, is not complete and therefore we cannot exclude the possibility that the remaining CD103<sup>+</sup> cDC1s and cDC2s are sufficient. Although we did not observe a correlation of CT2 and CT6 Foxp3 induction with CD103<sup>+</sup> cDC numbers (cDC1 or cDC2s), new tools with complete deletion of CD103<sup>+</sup> cDC1s and cDC2s will be required to definitively address the role of these cDCs in pTreg cell generation in vivo.</p><p>Our results showing that CD103<sup>+</sup> cDC1s are more efficient than cDC2s for pTreg cell induction in vitro is consistent with previous reports on the total CD103<sup>+</sup> cDC population (<xref ref-type="bibr" rid="bib17">Coombes et al., 2007</xref>; <xref ref-type="bibr" rid="bib66">Sun et al., 2007</xref>). It therefore remains possible that certain bacterial or food antigens in the gut may utilize this quantitative difference between the cDC subsets in pTreg cell induction in vivo. Although future studies are required, our data imply that these antigens would be present at high dose and would be preferentially acquired by cDC1s. However, the fact that cDC1-deficient mice do not appear to suffer from spontaneous gut immunopathology (<xref ref-type="bibr" rid="bib78">Welty et al., 2013</xref>) suggests that these antigens do not represent a major component of gut tolerance.</p><p>Our data suggest that commensal-specific pTreg cell differentiation can take place when cDCs carrying cognate antigen are permissive to pTreg cell induction such that they do not deliver a signal that terminally differentiates T cells into a FOXP3<sup>–</sup> effector T cell lineage. This fits well with data suggesting that the MLN stroma environment is intrinsically pTreg cell-inducing (<xref ref-type="bibr" rid="bib18">Cording et al., 2014</xref>; <xref ref-type="bibr" rid="bib23">Esterházy et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Fletcher et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Pezoldt et al., 2018</xref>), which would influence the function of all cDC subsets at homeostasis in the absence of inflammatory cues. In accordance with this idea, other groups have found that the tolerogenic milieus of skin and tumors induce a pro-Treg cell-inducing gene signature that is common across migratory cDC subsets (<xref ref-type="bibr" rid="bib2">Anandasabapathy et al., 2014</xref>; <xref ref-type="bibr" rid="bib54">Nirschl et al., 2017</xref>). It is notable that CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s did not express factors associated with increased cDC-mediated Treg induction such as RALDH activity or <italic>Ido1</italic> and <italic>Itgb8</italic> expression (<xref ref-type="bibr" rid="bib7">Boucard-Jourdin et al., 2016</xref>; <xref ref-type="bibr" rid="bib17">Coombes et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Matteoli et al., 2010</xref>; <xref ref-type="bibr" rid="bib66">Sun et al., 2007</xref>), which may explain the decreased ability of CD103<sup>–</sup> CD11b<sup>+</sup> cDC2s to promote Foxp3 induction in vitro compared to CD103<sup>+</sup> cDC1s. This also implies that there may be additional cDC or environmental factors that promote Foxp3 induction in the gut.</p><p>We do not believe that every T:DC interaction during homeostasis is required to induce a binary Treg vs T effector cell outcome. Even if the T cell does not upregulate FOXP3 after activation by the cDC, the cells may adopt a ‘Th0’ phenotype which retains the ability to subsequently upregulate FOXP3 or other lineage-specifying transcription factors. Support for this comes from our observation that CNS1-deficient T cells, which show little to no upregulation of Foxp3 at 1 week, appear to undergo induction of Foxp3 at later times points (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). Similarly, the frequency of Foxp3<sup>+</sup> cells continues to increase after 1 week of adoptive transfer of naïve T cells, although this may also be due to relative expansion (<xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>). Finally, in vitro activated Foxp3<sup>–</sup> T cells transferred in vivo can still undergo Foxp3 induction given the right TCR as long as the cells were not exposed to Th1- or Th2-inducing cytokines in vitro. Thus, pTreg cell selection may be termed ‘recessive’ as all cDC subsets presenting antigen would be required to be permissive for this process.</p><p>We predict that the homeostatic pTreg cell selection process can be disrupted by T cell encounter with cDCs expressing signals that induce effector phenotypes and block FOXP3 induction. As proof of concept, we showed that TCR transgenic cells exposed to Th1 or Th2 cytokines in vitro no longer undergo pTreg cell selection in vivo, confirming previous in vitro results (<xref ref-type="bibr" rid="bib11">Caretto et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Wei et al., 2007</xref>). In addition, TCR transgenic cells co-expressing a Th1 TCR, which engages cDCs other than that seen by the Helicobacter<italic>-</italic>specific TCR, also failed to upregulate Foxp3. Together, these data suggest a model whereby pTreg cell selection by tolerogenic cDCs is ‘recessive’ to cDCs that dominantly induce effector T cell development. This mechanism provides a satisfying model for operation of the gut adaptive immune system. Anti-inflammatory pTreg production would dominate during homeostatic conditions in the presence of typical commensal microbiota, whereas pro-inflammatory effector T cells, and not pTreg cells, would emerge when a pathogen is sensed. If antigen is carried by multiple cDC subsets, then naïve antigen-specific T cells could potentially differentiate into multiple effector T cell subsets in the correct contexts. The result is a careful balance between steady-state functional tolerance and focused anti-microbial responses that help preserve gut function in the context of time-varying microbial populations.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Antibody</td><td>Anti-mouse CD3ε (clone# 145–2 C11) FITC, PE, and BV421</td><td>Biolegend</td><td>100305/07/35</td><td>Dilution: 1:300</td></tr><tr><td>Antibody</td><td>Anti-mouse/human B220 (clone# RA3-6B2) APC/Cy7 and A700</td><td valign="top">Biolegend</td><td>103223/31</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td>Anti-mouse CD19 (clone# 6D5) APC/Cy7</td><td>Biolegend</td><td>115529</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td>Anti-mouse I-Ab (clone# AF6-120.1) APC and PerCP/Cy5.5</td><td>Biolegend</td><td>116417/15</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td>Anti-mouse CD11c (clone# N418) PE/Cy7 and BV605</td><td valign="top">Biolegend</td><td>117317/33</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse/human CD11b (clone# M1/70) BV711</td><td>Biolegend</td><td>101241</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD103 (clone# 2E7) BV421</td><td>Biolegend</td><td>121421</td><td>Dilution: 1:300</td></tr><tr><td>Antibody</td><td>Anti-mouse CD4 (clone# RM4-5) BV711, PE, and PB</td><td>Biolegend</td><td>100549/11/34</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td>Anti-mouse CD25 (clone# PC61) APC, BV605, PerCP/Cy5.5, and PE-Cy7</td><td>Biolegend</td><td>102011/35/29/15</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td>Anti-mouse/human CD44 (clone# IM7) APC/Cy7 and BV605</td><td>Biolegend</td><td>103027/47</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD62L (clone# MEL-14) APC/Cy7 and BV605</td><td valign="top">Biolegend</td><td valign="top">104427/37</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse FOXP3 (clone# FJK-16s) FITC</td><td valign="top">Thermo Fisher</td><td valign="top">11-5773-82</td><td>Dilution: 1:200</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse GATA3 (clone# 16E10A23) PE</td><td valign="top">Biolegend</td><td valign="top">653803</td><td>Dilution: 1:30</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse RORγt (clone# B2D) APC</td><td valign="top">Thermo Fisher</td><td valign="top">17-6981-80</td><td>Dilution: 1:200</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse TBET (clone# 4B10) PE/Cy7</td><td valign="top">Biolegend</td><td valign="top">644823</td><td>Dilution: 1:200</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse HELIOS (clone# 22F6) A647</td><td valign="top">Biolegend</td><td valign="top">137208</td><td>Dilution: 1:200</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CXCR3 (clone# CXCR3-173) BV421</td><td valign="top">Biolegend</td><td valign="top">126521</td><td>Dilution: 1:300</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse Thy1.1 (clone# 30-H12) PE/Cy7</td><td valign="top">Biolegend</td><td valign="top">105325</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse LAP (clone# TW7-16B4) BV421</td><td valign="top">Biolegend</td><td valign="top">141407</td><td>Dilution: 1:100</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD51 (clone# RMV-7) PE</td><td valign="top">Biolegend</td><td valign="top">104105</td><td>Dilution: 1:200</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD80 (clone# 16-10A1) APC</td><td valign="top">Biolegend</td><td valign="top">104713</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD86 (clone# GL-1) BV605</td><td valign="top">Biolegend</td><td valign="top">105037</td><td>Dilution: 1:300</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD40 (clone# 3/23) APC</td><td valign="top">Biolegend</td><td valign="top">124611</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD273 (clone# TY25) APC</td><td valign="top">Biolegend</td><td valign="top">107210</td><td>Dilution: 1:300</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD274 (clone# 10F.9G2) BV421</td><td valign="top">Biolegend</td><td valign="top">124315</td><td>Dilution: 1:300</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse XCR1 (clone# ZET) APC</td><td valign="top">Biolegend</td><td valign="top">148205</td><td>Dilution: 1:300</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD36 (clone# CRF D-2712) PE</td><td valign="top">Becton Dickinson</td><td valign="top">562702</td><td>Dilution: 1:200</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD45.1 (clone# A20) PE, APC, and PE/Cy7</td><td valign="top">Biolegend</td><td valign="top">110707/14/29</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD45.2 (clone# 104) PE, APC, PE/Cy7, and A700</td><td valign="top">Biolegend</td><td valign="top">109807/14/29/21</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse VB6 (clone# RR4-7) PE and APC</td><td valign="top">Biolegend</td><td valign="top">140003/5</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse Va2 (clone# B20.1) APC/Cy7 and PerCP/Cy5.5</td><td valign="top">Biolegend</td><td valign="top">127818/13</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse VB5 (clone# MR9-4) PE</td><td valign="top">Biolegend</td><td valign="top">139503</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse F4/80 (clone# BM8) PE/Cy7</td><td valign="top">Biolegend</td><td valign="top">123113</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse SIRPα (clone# P84) A700</td><td valign="top">Biolegend</td><td valign="top">144021</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD24 (clone# M1/69) PE</td><td valign="top">Biolegend</td><td valign="top">101807</td><td>Dilution: 1:750</td></tr><tr><td>Antibody</td><td valign="top">Anti-mouse CD101 (clone# Moushi101) PE/Cy7</td><td valign="top">Thermo Fisher</td><td valign="top">50-112-3316</td><td>Dilution: 1:300</td></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>OT-II TCR transgenic mice</td><td>The Jackson Laboratory (JAX)</td><td>#004194</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td><italic>Ccr7</italic><sup>GFP</sup> knockin/knockout mice</td><td>The Jackson Laboratory (JAX)</td><td>#027913</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>Itgax-Cre mice</td><td>The Jackson Laboratory (JAX)</td><td>#008068</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td><italic>Irf4</italic><sup>fl/fl</sup> mice</td><td>The Jackson Laboratory (JAX)</td><td>#009380</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>CT2 TCR transgenic mice</td><td><xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref></td><td/><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>CT6 TCR transgenic mice</td><td><xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref></td><td/><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td><italic>Rag1</italic><sup>–/–</sup> mice</td><td>The Jackson Laboratory (JAX)</td><td>#002216</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td><italic>Foxp3</italic><sup>IRES-GFP</sup>mice</td><td>The Jackson Laboratory (JAX)</td><td>#006772</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td><italic>Foxp3</italic><sup>IRES-Thy1.1</sup>mice</td><td><xref ref-type="bibr" rid="bib44">Liston et al., 2008</xref></td><td/><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td><italic>Irf8<sup>Δ149en/Δ149en</sup></italic> mice; formerly <italic>Irf8</italic> +32 5’<sup>–/–</sup></td><td><xref ref-type="bibr" rid="bib20">Durai et al., 2019</xref></td><td/><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td><italic>Batf3<sup>–/–</sup></italic> mice</td><td><xref ref-type="bibr" rid="bib30">Hildner et al., 2008</xref></td><td/><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td><italic>Zbtb46</italic><sup>GFP</sup> mice</td><td><xref ref-type="bibr" rid="bib61">Satpathy et al., 2012</xref></td><td/><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>CD207-DTA mice; formerly huLangerin-DTA</td><td><xref ref-type="bibr" rid="bib36">Kaplan et al., 2005</xref></td><td/><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>Animal breeding and experiments were performed in a specific pathogen-free animal facility using protocols approved by the Washington University Institutional Animal Care and Use Committee (protocol #20170036). Littermates were used for all comparisons of control and cDC-deficient mice. CT2, CT6, and OT-II transgenic mice were bred to <italic>Rag1</italic><sup>–/–</sup> and <italic>Foxp3</italic><sup>IRES-GFP</sup> (<xref ref-type="bibr" rid="bib43">Lin et al., 2007</xref>) or <italic>Foxp3</italic><sup>IRES-Thy1.1</sup> (<xref ref-type="bibr" rid="bib44">Liston et al., 2008</xref>).</p></sec><sec id="s4-2"><title>Adoptive transfer and harvest of T cells</title><p>Lymph nodes and spleens were harvested from congenically marked (Ly5.1, Ly5.2, or Ly5.1/2) CT2, CT6, or OT-II transgenic mice. Naïve T cells (CD4<sup>+</sup> Foxp3<sup>–</sup> CD25<sup>–</sup> CD62L<sup>hi</sup> CD44<sup>lo</sup>) were sorted on a FACSAria IIu (Becton Dickinson) and stained with CTV (Thermo Fisher #C34571). 5 × 10<sup>4</sup> (CT2/OT-II), or 10<sup>5</sup> (CT6) cells were retro-orbitally injected into 3–4-week-old mice on day 0 unless otherwise noted. For OT-II transfer in an oral tolerance model, mice were gavaged with 50 mg of OVA (Sigma #A5503) on days 1 and 2. CT2 and CT6 cells were analyzed by flow cytometry (Flowjo) in the dMLN on day 7, while OT-II cells were analyzed from the whole MLN on day 8. For analysis of polyclonal cLP T cells, colons were processed as in <xref ref-type="bibr" rid="bib55">Nutsch et al., 2016</xref>. Briefly, colons were cleaned and incubated in RPMI (Thermo Fisher # SH3025502) with 3% bovine calf serum, 20 mM HEPES, dithiothreitol (Sigma #43819), and EDTA for 20 min at 37°C with constant stirring. Tissue was further digested with 28.3 μg/ml Liberase TL (Sigma #5401020001) and 200 μg/ml deoxyribonuclease I (Sigma #DN25), with continuous stirring at 37°C for 30 min. Digested tissue was forced through a Cellector tissue sieve (Bellco Glass) and passed through a 40 μm cell strainer. Transcription factors were stained using the FOXP3/Transcription Factor Staining Buffer Set (Thermo Fisher #00-5523-00).</p></sec><sec id="s4-3"><title>Preparation of DCs</title><p>DCs were harvested from the dMLN of 3–5-week-old Ly5.1 <italic>Foxp3</italic><sup>IRES-GFP</sup> mice in our colony for ex vivo and fluorescence-activated cell sorting (FACS) experiments, and from cDC deficient mice for qPCR experiments. dMLN were dissociated in RPMI containing 5% bovine calf serum, penicillin/streptomycin, 1 mM sodium pyruvate, non-essential amino acids, 50 μM beta-mercaptoethanol, 65.8 μg/ml collagenase VIII (Sigma # C2139), and 0.2 U/ml dispase (Thermo Fisher # CB-40235) for 45 min at 37°C with continuous stirring. For culture and qPCR, DCs were blocked in 10 μg/ml anti-CD16/CD32 (BioXCell #BE0307) and sorted using the following markers: migratory cDCs (CD3ε<sup>–</sup> B220<sup>–</sup> CD19<sup>–</sup> IAb<sup>hi</sup> CD11c<sup>int</sup>), resident cDCs (CD3ε<sup>–</sup> B220<sup>–</sup> CD19<sup>–</sup> IAb<sup>int</sup> CD11c<sup>hi</sup>), CD103<sup>+</sup> SP (CD3ε<sup>–</sup> B220<sup>–</sup> CD19<sup>–</sup> IAb<sup>hi</sup> CD11c<sup>int</sup> CD103<sup>+</sup> CD11b<sup>–</sup>), DP (CD3ε<sup>–</sup> B220<sup>–</sup> CD19<sup>–</sup> IAb<sup>hi</sup> CD11c<sup>int</sup> CD103<sup>+</sup> CD11b<sup>+</sup>), and CD11b<sup>+</sup> SP (CD3ε<sup>–</sup> B220<sup>–</sup> CD19<sup>–</sup> IAb<sup>hi</sup> CD11c<sup>int</sup> CD103<sup>–</sup> CD11b<sup>+</sup>). RALDH activity was quantified using Aldefluor (Stemcell #01700).</p><p>Ex vivo cDC-T cell simulation assay cDCs with indicated phenotypes were sorted by flow cytometry from the dMLN of 10–15 mice naturally colonized by vertical transmission of <italic>H. typhlonius</italic> and <italic>H. apodemus.</italic> 10<sup>4</sup> cDCs were cultured with 2.5 × 10<sup>4</sup> naïve (CD4<sup>+</sup> Foxp3<sup>–</sup> CD25<sup>–</sup> CD44<sup>lo</sup> CD62L<sup>hi</sup>) CT2, CT6, or OT-II T cells sorted from transgenic mice. Cells were cultured in 96-well U-bottom plates for 2 days at 37°C in 200 μl complete DMEM (Thermo Fisher #SH3008101) with 10% FBS, glutamax, 50 μM beta-mercaptoethanol, and 1 mM sodium pyruvate (10 mM HEPES, non-essential amino acids, and penicillin/streptomycin). <italic>H. typhlonius</italic> and <italic>H. apodemus</italic> were cultured as in <xref ref-type="bibr" rid="bib15">Chai et al., 2017</xref>, autoclaved, filtered, and quantified for protein concentration by Bradford protein assay. Where noted, either 2 ng/μl of autoclaved <italic>H. typhlonius</italic> or 1.4 ng/μl of autoclaved <italic>H. apodemus</italic> was added to individual cultures. Where noted, cDC:T cell cocultures were incubated with 0.025 μg/μl αMHC Class II blocking antibody (a different clone from the non-blocking IAb antibody used to sort cDCs) (BioXCell #BE010). For cultures with OT-II T cells, indicated concentrations of OVA<sup>323-339</sup> were added to cultures. For T cell hybridoma stimulation by ex vivo cDCs, 10<sup>4</sup> CT6 or TA1 hybridomas were incubated with 10<sup>4 </sup>ex vivo MLN cDCs as described above. Where noted, 20 μg/ml anti-CD3 (BioXCell BE0001-1) was added to each well as a positive control. qPCR cDCs with indicated markers were sorted into lysis buffer and processed for RNA with the Nucleospin RNA XS kit (Machery-Nagel 740902). cDNA was synthesized with SuperScript III Reverse Transcriptase (ThermoFisher 18080085). qPCR was carried out with Luminaris Color HiGreen qPCR Master Mix (ThermoFisher K0391) using a LightCycler 480 (Roche) for real-time quantitative RT-PCR. Transcripts were normalized to <italic>Gapdh</italic> and quantified in two technological replicates. Primer pairs used were: <italic>Gapdh</italic> (F: 5’-<named-content content-type="sequence">ACAAGATGGTGAAGGTCGGTGTGA</named-content>-3’, R: 5’-<named-content content-type="sequence">AGCTTCCCATTCTCAGCCTTGACT</named-content>-3’) (<xref ref-type="bibr" rid="bib81">Zhou et al., 2014</xref>), <italic>Tgfβ1</italic> (F: 5’-<named-content content-type="sequence">GCTACCATGCCAACTTCTGT</named-content>-3’, R:5’-<named-content content-type="sequence">CGTAGTAGACGATGGGCAGT</named-content>-3’) (<xref ref-type="bibr" rid="bib39">Kuczma et al., 2009</xref>), <italic>Tgfβ2</italic> (F: 5’-<named-content content-type="sequence">TCGACATGGATCAGTTTATGCG</named-content>-3', R: 5’-<named-content content-type="sequence">CCCTGGTACTGTTGTAGATGGA</named-content>-3') (<xref ref-type="bibr" rid="bib42">Li et al., 2013</xref>), <italic>Tgfβ3</italic> (F: 5’-<named-content content-type="sequence">CGAGTGGCTGTTGAGGAGA</named-content>-3', R: 5’-<named-content content-type="sequence">GCTGAAAGGTGTGACATGGA</named-content>-3') (<xref ref-type="bibr" rid="bib19">de Verteuil et al., 2014</xref>), <italic>Il10</italic> (F: 5’-<named-content content-type="sequence">AGTGGAGCAGGTGAAGAGTG</named-content>-3', R: 5’-<named-content content-type="sequence">TTCGGAGAGAGGTACAAACG</named-content>-3') (<xref ref-type="bibr" rid="bib39">Kuczma et al., 2009</xref>), <italic>Itgβ6</italic> (F: 5’-<named-content content-type="sequence">AAACGGGAACCAATCCTCTGT</named-content>-3', R: 5’-<named-content content-type="sequence">GCTTCTCCCTGTGCTTGTAGG</named-content>-3') (<xref ref-type="bibr" rid="bib69">Tatler et al., 2016</xref>), <italic>Itgβ8</italic> (F: 5’-<named-content content-type="sequence">CTGAAGAAATACCCCGTGGA</named-content>-3', R: 5’-<named-content content-type="sequence">ATGGGGAGGCATACAGTCT</named-content>-3’) (<xref ref-type="bibr" rid="bib50">Melton et al., 2010</xref>), <italic>Ido1</italic>(F: 5’-<named-content content-type="sequence">GAAGGATCCTTGAAGACCAC</named-content>-3', R: 5’-<named-content content-type="sequence">GAAGCTGCGATTTCCACCAA</named-content>-3') (<xref ref-type="bibr" rid="bib57">Orabona et al., 2006</xref>).</p></sec><sec id="s4-4"><title>16S rRNA sequencing</title><p>Fecal DNA was purified via column (Zymogenetics) and used in triplicate PCR of the bacterial V4 hypervariable region of 16S rRNA using barcoded primers described previously (<xref ref-type="bibr" rid="bib10">Caporaso et al., 2011</xref>). PCR products were sequenced using the Illumina MiSeq platform (2 × 250 bp paired end reads), and ASVs and taxonomy including species designations if possible (silva 1.32) determined by dada2 (<xref ref-type="bibr" rid="bib9">Callahan et al., 2016</xref>). ASV data were analyzed by phyloseq (v1.32), vegan (v2.4), and DESeq2 (v.1.28) in R (3.6).</p></sec><sec id="s4-5"><title>In vitro polarization and transduction of T cells</title><p>24-well plates were coated with 10 μg/ml anti-CD3ε (BioXCell BE0001-1) overnight at 4°C. Wells were washed with PBS and plated with 5–15 × 10<sup>5</sup> naïve CT6 T cells in D10 and 1 μg/ml anti-CD28 (BioXCell BE0015-1) in Th0 conditions: 10 μg/ml anti-TGFβ (BioXCell BE0057), 5 μg/ml anti-IL12 (BioXCell BE0052), 5 μg/ml anti-IFNγ (BioXCell BE0054), and (5 mg/ml anti-IL4 (BioXCell BE0045)); Th1-polarizing conditions: 10 ng/ml IL-12 (Peprotech #210–12); or Th2-polarizing conditions: 10 ng/ml IL-4 (Peprotech #214–14). For in vitro polarization experiments, naïve CT2 cells were plated on anti-CD3ε and cultured for 48 hr in Th0 or Th1 conditions, after which 1.5 × 10<sup>5</sup> cells were injected into each host. For TCR transduction, TCRα chains utilized were TA1: TRAV14-3*01 CDR3 AASETGNTGKLI; T7-2: TRAV7-4*01 CDR3 AASEHWSNYQLI; and T9-1: TRAV9-1*02 CDR3 AVSAPNTNKVV. TCRα chain retroviral transduction was performed as described in <xref ref-type="bibr" rid="bib32">Hsieh et al., 2004</xref> using TransIT-293 (Thermo Fisher # MIR2700). Note that the transduced cells all share the same original TCli TCRβ chain (<xref ref-type="bibr" rid="bib32">Hsieh et al., 2004</xref>). CT6 cells were plated on anti-CD3 in Th0 media, transduced 27 hr later, and left to rest in Th0 media for 48–66 hr. Foxp3<sup>–</sup> cells were then sorted for TA1-transduced (TdTomato<sup>+</sup>), control TCR-transduced (Thy1.1<sup>+</sup>), or untransduced cells. 5 × 10<sup>4</sup> (co-injection of transduced TCRs totaling 1.5 × 10<sup>5</sup> T cells per mouse) or 2 × 10<sup>5</sup> (injection of single transduced TCR plus untransduced control cells) of each TCR were injected into each host. T cell hybridomas expressing GFP under a minimal NFAT promoter (<xref ref-type="bibr" rid="bib35">Ise et al., 2010</xref>) were retrovirally transduced with CT6 or TA1 TCRα chains as previously described (<xref ref-type="bibr" rid="bib15">Chai et al., 2017</xref>; <xref ref-type="bibr" rid="bib40">Lathrop et al., 2011</xref>).</p></sec><sec id="s4-6"><title>Statistical analysis</title><p>Graphpad Prism v7 was used for statistical and graphical analysis unless noted. CTV division index was obtained by manually defining CTV peaks for each cell population and using the formula <inline-formula><mml:math id="inf1"><mml:mfrac><mml:mrow><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo>×</mml:mo></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mfenced separators="|"><mml:mrow> <mml:mi mathvariant="normal"/><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></inline-formula>, where (i) = the maximum number of cell divisions in the population and (<italic>N</italic>) = the number of cells in a given CTV peak (i). Student’s t-test was used for between-subject analyses with two groups. One-way ANOVA with Tukey’s multiple comparisons tests was used for between-subjects analysis with greater than two groups and one independent variable. Two-way ANOVA with Sidak’s multiple comparisons tests was used for between-subjects analysis with greater than two groups and two independent variables. Where stated, the mixed effects model with Tukey’s multiple comparisons tests were used instead of two-way ANOVA for repeated measures data with missing values. For in vivo experiments, each dot represents data from an individual host. Bars indicate mean ± SEM. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Nicole Santacruz and Patricia Hsieh for technical assistance (Wash.U.). We thank Jessica Hoisington-Lopez at the Center for Genome Sciences and Systems Biology for Miseq sequencing expertise (Wash.U.).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Validation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Resources, Software, Supervision, Visualization, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Resources, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Resources, Software, Formal analysis, Supervision, Funding acquisition, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were performed in strict accordance with the guidelines of the Institutional Animal Care and Use Committee at Washington University (Protocol Number: 20170036).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-54792-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>16S rRNA sequencing data has been deposited in ENA (PRJEB42640).</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Russler-Germain</surname><given-names>EV</given-names></name><name><surname>Hsieh</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Fecal 16S samples from CD207-DTA and Irf8-Delta149en cDC deficient mice</data-title><source>European Nucleotide Archive</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/ena/browser/view/PRJEB42640">PRJEB42640</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allan</surname> <given-names>RS</given-names></name><name><surname>Waithman</surname> <given-names>J</given-names></name><name><surname>Bedoui</surname> <given-names>S</given-names></name><name><surname>Jones</surname> <given-names>CM</given-names></name><name><surname>Villadangos</surname> <given-names>JA</given-names></name><name><surname>Zhan</surname> <given-names>Y</given-names></name><name><surname>Lew</surname> <given-names>AM</given-names></name><name><surname>Shortman</surname> <given-names>K</given-names></name><name><surname>Heath</surname> <given-names>WR</given-names></name><name><surname>Carbone</surname> <given-names>FR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming</article-title><source>Immunity</source><volume>25</volume><fpage>153</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.04.017</pub-id><pub-id pub-id-type="pmid">16860764</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anandasabapathy</surname> <given-names>N</given-names></name><name><surname>Feder</surname> <given-names>R</given-names></name><name><surname>Mollah</surname> <given-names>S</given-names></name><name><surname>Tse</surname> <given-names>S-W</given-names></name><name><surname>Longhi</surname> <given-names>MP</given-names></name><name><surname>Mehandru</surname> <given-names>S</given-names></name><name><surname>Matos</surname> <given-names>I</given-names></name><name><surname>Cheong</surname> <given-names>C</given-names></name><name><surname>Ruane</surname> <given-names>D</given-names></name><name><surname>Brane</surname> <given-names>L</given-names></name><name><surname>Teixeira</surname> <given-names>A</given-names></name><name><surname>Dobrin</surname> <given-names>J</given-names></name><name><surname>Mizenina</surname> <given-names>O</given-names></name><name><surname>Park</surname> <given-names>CG</given-names></name><name><surname>Meredith</surname> <given-names>M</given-names></name><name><surname>Clausen</surname> <given-names>BE</given-names></name><name><surname>Nussenzweig</surname> <given-names>MC</given-names></name><name><surname>Steinman</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Classical Flt3L-dependent dendritic cells control immunity to protein vaccine</article-title><source>Journal of Experimental Medicine</source><volume>211</volume><fpage>1875</fpage><lpage>1891</lpage><pub-id pub-id-type="doi">10.1084/jem.20131397</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Shima</surname> <given-names>T</given-names></name><name><surname>Imaoka</surname> <given-names>A</given-names></name><name><surname>Kuwahara</surname> <given-names>T</given-names></name><name><surname>Momose</surname> <given-names>Y</given-names></name><name><surname>Cheng</surname> <given-names>G</given-names></name><name><surname>Yamasaki</surname> <given-names>S</given-names></name><name><surname>Saito</surname> <given-names>T</given-names></name><name><surname>Ohba</surname> <given-names>Y</given-names></name><name><surname>Taniguchi</surname> <given-names>T</given-names></name><name><surname>Takeda</surname> <given-names>K</given-names></name><name><surname>Hori</surname> <given-names>S</given-names></name><name><surname>Ivanov</surname> <given-names>II</given-names></name><name><surname>Umesaki</surname> <given-names>Y</given-names></name><name><surname>Itoh</surname> <given-names>K</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Induction of colonic regulatory T cells by indigenous Clostridium species</article-title><source>Science</source><volume>331</volume><fpage>337</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1126/science.1198469</pub-id><pub-id pub-id-type="pmid">21205640</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bain</surname> <given-names>CC</given-names></name><name><surname>Montgomery</surname> <given-names>J</given-names></name><name><surname>Scott</surname> <given-names>CL</given-names></name><name><surname>Kel</surname> <given-names>JM</given-names></name><name><surname>Girard-Madoux</surname> <given-names>MJH</given-names></name><name><surname>Martens</surname> <given-names>L</given-names></name><name><surname>Zangerle-Murray</surname> <given-names>TFP</given-names></name><name><surname>Ober-Blöbaum</surname> <given-names>J</given-names></name><name><surname>Lindenbergh-Kortleve</surname> <given-names>D</given-names></name><name><surname>Samsom</surname> <given-names>JN</given-names></name><name><surname>Henri</surname> <given-names>S</given-names></name><name><surname>Lawrence</surname> <given-names>T</given-names></name><name><surname>Saeys</surname> <given-names>Y</given-names></name><name><surname>Malissen</surname> <given-names>B</given-names></name><name><surname>Dalod</surname> <given-names>M</given-names></name><name><surname>Clausen</surname> <given-names>BE</given-names></name><name><surname>Mowat</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Tgfβr signalling controls CD103<sup>+</sup>CD11b<sup>+</sup> dendritic cell development in the intestine</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>620</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00658-6</pub-id><pub-id pub-id-type="pmid">28931816</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blander</surname> <given-names>JM</given-names></name><name><surname>Longman</surname> <given-names>RS</given-names></name><name><surname>Iliev</surname> <given-names>ID</given-names></name><name><surname>Sonnenberg</surname> <given-names>GF</given-names></name><name><surname>Artis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulation of inflammation by Microbiota interactions with the host</article-title><source>Nature Immunology</source><volume>18</volume><fpage>851</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1038/ni.3780</pub-id><pub-id pub-id-type="pmid">28722709</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogunovic</surname> <given-names>M</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Helft</surname> <given-names>J</given-names></name><name><surname>Shang</surname> <given-names>L</given-names></name><name><surname>Hashimoto</surname> <given-names>D</given-names></name><name><surname>Greter</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>K</given-names></name><name><surname>Jakubzick</surname> <given-names>C</given-names></name><name><surname>Ingersoll</surname> <given-names>MA</given-names></name><name><surname>Leboeuf</surname> <given-names>M</given-names></name><name><surname>Stanley</surname> <given-names>ER</given-names></name><name><surname>Nussenzweig</surname> <given-names>M</given-names></name><name><surname>Lira</surname> <given-names>SA</given-names></name><name><surname>Randolph</surname> <given-names>GJ</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Origin of the Lamina propria dendritic cell network</article-title><source>Immunity</source><volume>31</volume><fpage>513</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.08.010</pub-id><pub-id pub-id-type="pmid">19733489</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucard-Jourdin</surname> <given-names>M</given-names></name><name><surname>Kugler</surname> <given-names>D</given-names></name><name><surname>Endale Ahanda</surname> <given-names>ML</given-names></name><name><surname>This</surname> <given-names>S</given-names></name><name><surname>De Calisto</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>A</given-names></name><name><surname>Mora</surname> <given-names>JR</given-names></name><name><surname>Stuart</surname> <given-names>LM</given-names></name><name><surname>Savill</surname> <given-names>J</given-names></name><name><surname>Lacy-Hulbert</surname> <given-names>A</given-names></name><name><surname>Paidassi</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>??8 integrin expression and activation of TGF-β by intestinal dendritic cells are determined by both tissue microenvironment and cell lineage</article-title><source>The Journal of Immunology</source><volume>197</volume><fpage>1968</fpage><lpage>1978</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600244</pub-id><pub-id pub-id-type="pmid">27481847</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>EM</given-names></name><name><surname>Kenny</surname> <given-names>DJ</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gut Microbiota regulation of T cells during inflammation and autoimmunity</article-title><source>Annual Review of Immunology</source><volume>37</volume><fpage>599</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-042718-041841</pub-id><pub-id pub-id-type="pmid">31026411</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callahan</surname> <given-names>BJ</given-names></name><name><surname>McMurdie</surname> <given-names>PJ</given-names></name><name><surname>Rosen</surname> <given-names>MJ</given-names></name><name><surname>Han</surname> <given-names>AW</given-names></name><name><surname>Johnson</surname> <given-names>AJ</given-names></name><name><surname>Holmes</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>DADA2: high-resolution sample inference from Illumina amplicon data</article-title><source>Nature Methods</source><volume>13</volume><fpage>581</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3869</pub-id><pub-id pub-id-type="pmid">27214047</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caporaso</surname> <given-names>JG</given-names></name><name><surname>Lauber</surname> <given-names>CL</given-names></name><name><surname>Walters</surname> <given-names>WA</given-names></name><name><surname>Berg-Lyons</surname> <given-names>D</given-names></name><name><surname>Lozupone</surname> <given-names>CA</given-names></name><name><surname>Turnbaugh</surname> <given-names>PJ</given-names></name><name><surname>Fierer</surname> <given-names>N</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample</article-title><source>PNAS</source><volume>108</volume><fpage>4516</fpage><lpage>4522</lpage><pub-id pub-id-type="doi">10.1073/pnas.1000080107</pub-id><pub-id pub-id-type="pmid">20534432</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caretto</surname> <given-names>D</given-names></name><name><surname>Katzman</surname> <given-names>SD</given-names></name><name><surname>Villarino</surname> <given-names>AV</given-names></name><name><surname>Gallo</surname> <given-names>E</given-names></name><name><surname>Abbas</surname> <given-names>AK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells</article-title><source>The Journal of Immunology</source><volume>184</volume><fpage>30</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0903412</pub-id><pub-id pub-id-type="pmid">19949064</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerovic</surname> <given-names>V</given-names></name><name><surname>Houston</surname> <given-names>SA</given-names></name><name><surname>Scott</surname> <given-names>CL</given-names></name><name><surname>Aumeunier</surname> <given-names>A</given-names></name><name><surname>Yrlid</surname> <given-names>U</given-names></name><name><surname>Mowat</surname> <given-names>AM</given-names></name><name><surname>Milling</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Intestinal CD103(-) dendritic cells migrate in lymph and prime effector T cells</article-title><source>Mucosal Immunology</source><volume>6</volume><fpage>104</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/mi.2012.53</pub-id><pub-id pub-id-type="pmid">22718260</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerovic</surname> <given-names>V</given-names></name><name><surname>Bain</surname> <given-names>CC</given-names></name><name><surname>Mowat</surname> <given-names>AM</given-names></name><name><surname>Milling</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intestinal macrophages and dendritic cells: what's the difference?</article-title><source>Trends in Immunology</source><volume>35</volume><fpage>270</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.it.2014.04.003</pub-id><pub-id pub-id-type="pmid">24794393</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerovic</surname> <given-names>V</given-names></name><name><surname>Houston</surname> <given-names>SA</given-names></name><name><surname>Westlund</surname> <given-names>J</given-names></name><name><surname>Utriainen</surname> <given-names>L</given-names></name><name><surname>Davison</surname> <given-names>ES</given-names></name><name><surname>Scott</surname> <given-names>CL</given-names></name><name><surname>Bain</surname> <given-names>CC</given-names></name><name><surname>Joeris</surname> <given-names>T</given-names></name><name><surname>Agace</surname> <given-names>WW</given-names></name><name><surname>Kroczek</surname> <given-names>RA</given-names></name><name><surname>Mowat</surname> <given-names>AM</given-names></name><name><surname>Yrlid</surname> <given-names>U</given-names></name><name><surname>Milling</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells</article-title><source>Mucosal Immunology</source><volume>8</volume><fpage>38</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1038/mi.2014.40</pub-id><pub-id pub-id-type="pmid">24850430</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname> <given-names>JN</given-names></name><name><surname>Peng</surname> <given-names>Y</given-names></name><name><surname>Rengarajan</surname> <given-names>S</given-names></name><name><surname>Solomon</surname> <given-names>BD</given-names></name><name><surname>Ai</surname> <given-names>TL</given-names></name><name><surname>Shen</surname> <given-names>Z</given-names></name><name><surname>Hsieh</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Helicobacter species are potent drivers of colonic T cell responses in homeostasis and inflammation</article-title><source>Science Immunology</source><volume>2</volume><elocation-id>eaal5068</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aal5068</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Jin</surname> <given-names>W</given-names></name><name><surname>Hardegen</surname> <given-names>N</given-names></name><name><surname>Lei</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Marinos</surname> <given-names>N</given-names></name><name><surname>McGrady</surname> <given-names>G</given-names></name><name><surname>Wahl</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3</article-title><source>Journal of Experimental Medicine</source><volume>198</volume><fpage>1875</fpage><lpage>1886</lpage><pub-id pub-id-type="doi">10.1084/jem.20030152</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coombes</surname> <given-names>JL</given-names></name><name><surname>Siddiqui</surname> <given-names>KRR</given-names></name><name><surname>Arancibia-Cárcamo</surname> <given-names>CV</given-names></name><name><surname>Hall</surname> <given-names>J</given-names></name><name><surname>Sun</surname> <given-names>C-M</given-names></name><name><surname>Belkaid</surname> <given-names>Y</given-names></name><name><surname>Powrie</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism</article-title><source>Journal of Experimental Medicine</source><volume>204</volume><fpage>1757</fpage><lpage>1764</lpage><pub-id pub-id-type="doi">10.1084/jem.20070590</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cording</surname> <given-names>S</given-names></name><name><surname>Wahl</surname> <given-names>B</given-names></name><name><surname>Kulkarni</surname> <given-names>D</given-names></name><name><surname>Chopra</surname> <given-names>H</given-names></name><name><surname>Pezoldt</surname> <given-names>J</given-names></name><name><surname>Buettner</surname> <given-names>M</given-names></name><name><surname>Dummer</surname> <given-names>A</given-names></name><name><surname>Hadis</surname> <given-names>U</given-names></name><name><surname>Heimesaat</surname> <given-names>M</given-names></name><name><surname>Bereswill</surname> <given-names>S</given-names></name><name><surname>Falk</surname> <given-names>C</given-names></name><name><surname>Bode</surname> <given-names>U</given-names></name><name><surname>Hamann</surname> <given-names>A</given-names></name><name><surname>Fleissner</surname> <given-names>D</given-names></name><name><surname>Huehn</surname> <given-names>J</given-names></name><name><surname>Pabst</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The intestinal micro-environment imprints stromal cells to promote efficient treg induction in gut-draining lymph nodes</article-title><source>Mucosal Immunology</source><volume>7</volume><fpage>359</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1038/mi.2013.54</pub-id><pub-id pub-id-type="pmid">23945546</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Verteuil</surname> <given-names>DA</given-names></name><name><surname>Rouette</surname> <given-names>A</given-names></name><name><surname>Hardy</surname> <given-names>M-P</given-names></name><name><surname>Lavallée</surname> <given-names>S</given-names></name><name><surname>Trofimov</surname> <given-names>A</given-names></name><name><surname>Gaucher</surname> <given-names>É</given-names></name><name><surname>Perreault</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Immunoproteasomes Shape the Transcriptome and Regulate the Function of Dendritic Cells</article-title><source>The Journal of Immunology</source><volume>193</volume><fpage>1121</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1400871</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durai</surname> <given-names>V</given-names></name><name><surname>Bagadia</surname> <given-names>P</given-names></name><name><surname>Granja</surname> <given-names>JM</given-names></name><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Kulkarni</surname> <given-names>DH</given-names></name><name><surname>Davidson</surname> <given-names>JT</given-names></name><name><surname>Wu</surname> <given-names>R</given-names></name><name><surname>Patel</surname> <given-names>SJ</given-names></name><name><surname>Iwata</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>TT</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name><name><surname>Briseño</surname> <given-names>CG</given-names></name><name><surname>Grajales-Reyes</surname> <given-names>GE</given-names></name><name><surname>Wöhner</surname> <given-names>M</given-names></name><name><surname>Tagoh</surname> <given-names>H</given-names></name><name><surname>Kee</surname> <given-names>BL</given-names></name><name><surname>Newberry</surname> <given-names>RD</given-names></name><name><surname>Busslinger</surname> <given-names>M</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name><name><surname>Murphy</surname> <given-names>TL</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cryptic activation of an Irf8 enhancer governs cDC1 fate specification</article-title><source>Nature Immunology</source><volume>20</volume><fpage>1161</fpage><lpage>1173</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0450-x</pub-id><pub-id pub-id-type="pmid">31406378</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durai</surname> <given-names>V</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Functions of murine dendritic cells</article-title><source>Immunity</source><volume>45</volume><fpage>719</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.10.010</pub-id><pub-id pub-id-type="pmid">27760337</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esterházy</surname> <given-names>D</given-names></name><name><surname>Loschko</surname> <given-names>J</given-names></name><name><surname>London</surname> <given-names>M</given-names></name><name><surname>Jove</surname> <given-names>V</given-names></name><name><surname>Oliveira</surname> <given-names>TY</given-names></name><name><surname>Mucida</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Classical dendritic cells are required for dietary antigen-mediated induction of peripheral T(reg) cells and tolerance</article-title><source>Nature Immunology</source><volume>17</volume><fpage>545</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1038/ni.3408</pub-id><pub-id pub-id-type="pmid">27019226</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esterházy</surname> <given-names>D</given-names></name><name><surname>Canesso</surname> <given-names>MCC</given-names></name><name><surname>Mesin</surname> <given-names>L</given-names></name><name><surname>Muller</surname> <given-names>PA</given-names></name><name><surname>de Castro</surname> <given-names>TBR</given-names></name><name><surname>Lockhart</surname> <given-names>A</given-names></name><name><surname>ElJalby</surname> <given-names>M</given-names></name><name><surname>Faria</surname> <given-names>AMC</given-names></name><name><surname>Mucida</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Compartmentalized gut lymph node drainage dictates adaptive immune responses</article-title><source>Nature</source><volume>569</volume><fpage>126</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1125-3</pub-id><pub-id pub-id-type="pmid">30988509</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farache</surname> <given-names>J</given-names></name><name><surname>Koren</surname> <given-names>I</given-names></name><name><surname>Milo</surname> <given-names>I</given-names></name><name><surname>Gurevich</surname> <given-names>I</given-names></name><name><surname>Kim</surname> <given-names>KW</given-names></name><name><surname>Zigmond</surname> <given-names>E</given-names></name><name><surname>Furtado</surname> <given-names>GC</given-names></name><name><surname>Lira</surname> <given-names>SA</given-names></name><name><surname>Shakhar</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Luminal Bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation</article-title><source>Immunity</source><volume>38</volume><fpage>581</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.01.009</pub-id><pub-id pub-id-type="pmid">23395676</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname> <given-names>AL</given-names></name><name><surname>Acton</surname> <given-names>SE</given-names></name><name><surname>Knoblich</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lymph node fibroblastic reticular cells in health and disease</article-title><source>Nature Reviews Immunology</source><volume>15</volume><fpage>350</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1038/nri3846</pub-id><pub-id pub-id-type="pmid">25998961</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname> <given-names>DM</given-names></name><name><surname>Hand</surname> <given-names>TW</given-names></name><name><surname>Han</surname> <given-names>SJ</given-names></name><name><surname>Gerner</surname> <given-names>MY</given-names></name><name><surname>Glatman Zaretsky</surname> <given-names>A</given-names></name><name><surname>Byrd</surname> <given-names>AL</given-names></name><name><surname>Harrison</surname> <given-names>OJ</given-names></name><name><surname>Ortiz</surname> <given-names>AM</given-names></name><name><surname>Quinones</surname> <given-names>M</given-names></name><name><surname>Trinchieri</surname> <given-names>G</given-names></name><name><surname>Brenchley</surname> <given-names>JM</given-names></name><name><surname>Brodsky</surname> <given-names>IE</given-names></name><name><surname>Germain</surname> <given-names>RN</given-names></name><name><surname>Randolph</surname> <given-names>GJ</given-names></name><name><surname>Belkaid</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Microbiota-Dependent sequelae of acute infection compromise Tissue-Specific immunity</article-title><source>Cell</source><volume>163</volume><fpage>354</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.08.030</pub-id><pub-id pub-id-type="pmid">26451485</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Förster</surname> <given-names>R</given-names></name><name><surname>Davalos-Misslitz</surname> <given-names>AC</given-names></name><name><surname>Rot</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>CCR7 and its ligands: balancing immunity and tolerance</article-title><source>Nature Reviews Immunology</source><volume>8</volume><fpage>362</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1038/nri2297</pub-id><pub-id pub-id-type="pmid">18379575</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname> <given-names>JG</given-names></name><name><surname>Gorelick</surname> <given-names>PL</given-names></name><name><surname>Kullberg</surname> <given-names>MC</given-names></name><name><surname>Ge</surname> <given-names>Z</given-names></name><name><surname>Dewhirst</surname> <given-names>FE</given-names></name><name><surname>Ward</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice</article-title><source>Infection and Immunity</source><volume>67</volume><fpage>1757</fpage><lpage>1762</lpage><pub-id pub-id-type="doi">10.1128/IAI.67.4.1757-1762.1999</pub-id><pub-id pub-id-type="pmid">10085015</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname> <given-names>H</given-names></name><name><surname>Matsumoto</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanisms of tolerance induction by dendritic cells In Vivo</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>350</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00350</pub-id><pub-id pub-id-type="pmid">29535726</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildner</surname> <given-names>K</given-names></name><name><surname>Edelson</surname> <given-names>BT</given-names></name><name><surname>Purtha</surname> <given-names>WE</given-names></name><name><surname>Diamond</surname> <given-names>M</given-names></name><name><surname>Matsushita</surname> <given-names>H</given-names></name><name><surname>Kohyama</surname> <given-names>M</given-names></name><name><surname>Calderon</surname> <given-names>B</given-names></name><name><surname>Schraml</surname> <given-names>BU</given-names></name><name><surname>Unanue</surname> <given-names>ER</given-names></name><name><surname>Diamond</surname> <given-names>MS</given-names></name><name><surname>Schreiber</surname> <given-names>RD</given-names></name><name><surname>Murphy</surname> <given-names>TL</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity</article-title><source>Science</source><volume>322</volume><fpage>1097</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1126/science.1164206</pub-id><pub-id pub-id-type="pmid">19008445</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hor</surname> <given-names>JL</given-names></name><name><surname>Whitney</surname> <given-names>PG</given-names></name><name><surname>Zaid</surname> <given-names>A</given-names></name><name><surname>Brooks</surname> <given-names>AG</given-names></name><name><surname>Heath</surname> <given-names>WR</given-names></name><name><surname>Mueller</surname> <given-names>SN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection</article-title><source>Immunity</source><volume>43</volume><fpage>554</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.07.020</pub-id><pub-id pub-id-type="pmid">26297566</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname> <given-names>CS</given-names></name><name><surname>Liang</surname> <given-names>Y</given-names></name><name><surname>Tyznik</surname> <given-names>AJ</given-names></name><name><surname>Self</surname> <given-names>SG</given-names></name><name><surname>Liggitt</surname> <given-names>D</given-names></name><name><surname>Rudensky</surname> <given-names>AY</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors</article-title><source>Immunity</source><volume>21</volume><fpage>267</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.07.009</pub-id><pub-id pub-id-type="pmid">15308106</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Chi</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Control of T Cell Fates and Immune Tolerance by p38α Signaling in Mucosal CD103 <sup>+</sup> Dendritic Cells</article-title><source>The Journal of Immunology</source><volume>191</volume><fpage>650</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1300398</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imam</surname> <given-names>T</given-names></name><name><surname>Park</surname> <given-names>S</given-names></name><name><surname>Kaplan</surname> <given-names>MH</given-names></name><name><surname>Olson</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Effector T helper cell subsets in inflammatory bowel diseases</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>1212</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01212</pub-id><pub-id pub-id-type="pmid">29910812</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ise</surname> <given-names>W</given-names></name><name><surname>Kohyama</surname> <given-names>M</given-names></name><name><surname>Nutsch</surname> <given-names>KM</given-names></name><name><surname>Lee</surname> <given-names>HM</given-names></name><name><surname>Suri</surname> <given-names>A</given-names></name><name><surname>Unanue</surname> <given-names>ER</given-names></name><name><surname>Murphy</surname> <given-names>TL</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms</article-title><source>Nature Immunology</source><volume>11</volume><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/ni.1835</pub-id><pub-id pub-id-type="pmid">20037585</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname> <given-names>DH</given-names></name><name><surname>Jenison</surname> <given-names>MC</given-names></name><name><surname>Saeland</surname> <given-names>S</given-names></name><name><surname>Shlomchik</surname> <given-names>WD</given-names></name><name><surname>Shlomchik</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity</article-title><source>Immunity</source><volume>23</volume><fpage>611</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2005.10.008</pub-id><pub-id pub-id-type="pmid">16356859</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>Galan</surname> <given-names>C</given-names></name><name><surname>Hill</surname> <given-names>AA</given-names></name><name><surname>Wu</surname> <given-names>WJ</given-names></name><name><surname>Fehlner-Peach</surname> <given-names>H</given-names></name><name><surname>Song</surname> <given-names>HW</given-names></name><name><surname>Schady</surname> <given-names>D</given-names></name><name><surname>Bettini</surname> <given-names>ML</given-names></name><name><surname>Simpson</surname> <given-names>KW</given-names></name><name><surname>Longman</surname> <given-names>RS</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name><name><surname>Diehl</surname> <given-names>GE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Critical role for the Microbiota in CX3CR1<sup>+</sup>intestinal mononuclear phagocyte regulation of intestinal T Cell Responses</article-title><source>Immunity</source><volume>49</volume><fpage>151</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.05.009</pub-id><pub-id pub-id-type="pmid">29980437</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinnebrew</surname> <given-names>MA</given-names></name><name><surname>Buffie</surname> <given-names>CG</given-names></name><name><surname>Diehl</surname> <given-names>GE</given-names></name><name><surname>Zenewicz</surname> <given-names>LA</given-names></name><name><surname>Leiner</surname> <given-names>I</given-names></name><name><surname>Hohl</surname> <given-names>TM</given-names></name><name><surname>Flavell</surname> <given-names>RA</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense</article-title><source>Immunity</source><volume>36</volume><fpage>276</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.12.011</pub-id><pub-id pub-id-type="pmid">22306017</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuczma</surname> <given-names>M</given-names></name><name><surname>Podolsky</surname> <given-names>R</given-names></name><name><surname>Garge</surname> <given-names>N</given-names></name><name><surname>Daniely</surname> <given-names>D</given-names></name><name><surname>Pacholczyk</surname> <given-names>R</given-names></name><name><surname>Ignatowicz</surname> <given-names>L</given-names></name><name><surname>Kraj</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Foxp3-deficient regulatory T cells do not revert into conventional effector CD4<sup>+</sup> T cells but constitute a unique cell subset</article-title><source>The Journal of Immunology</source><volume>183</volume><fpage>3731</fpage><lpage>3741</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0800601</pub-id><pub-id pub-id-type="pmid">19710455</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lathrop</surname> <given-names>SK</given-names></name><name><surname>Bloom</surname> <given-names>SM</given-names></name><name><surname>Rao</surname> <given-names>SM</given-names></name><name><surname>Nutsch</surname> <given-names>K</given-names></name><name><surname>Lio</surname> <given-names>CW</given-names></name><name><surname>Santacruz</surname> <given-names>N</given-names></name><name><surname>Peterson</surname> <given-names>DA</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name><name><surname>Hsieh</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Peripheral education of the immune system by colonic commensal Microbiota</article-title><source>Nature</source><volume>478</volume><fpage>250</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1038/nature10434</pub-id><pub-id pub-id-type="pmid">21937990</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname> <given-names>KL</given-names></name><name><surname>Caton</surname> <given-names>ML</given-names></name><name><surname>Bogunovic</surname> <given-names>M</given-names></name><name><surname>Greter</surname> <given-names>M</given-names></name><name><surname>Grajkowska</surname> <given-names>LT</given-names></name><name><surname>Ng</surname> <given-names>D</given-names></name><name><surname>Klinakis</surname> <given-names>A</given-names></name><name><surname>Charo</surname> <given-names>IF</given-names></name><name><surname>Jung</surname> <given-names>S</given-names></name><name><surname>Gommerman</surname> <given-names>JL</given-names></name><name><surname>Ivanov</surname> <given-names>II</given-names></name><name><surname>Liu</surname> <given-names>K</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name><name><surname>Reizis</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine</article-title><source>Immunity</source><volume>35</volume><fpage>780</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.08.013</pub-id><pub-id pub-id-type="pmid">22018469</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Asahina</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury</article-title><source>PNAS</source><volume>110</volume><fpage>2324</fpage><lpage>2329</lpage><pub-id pub-id-type="doi">10.1073/pnas.1214136110</pub-id><pub-id pub-id-type="pmid">23345421</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>W</given-names></name><name><surname>Haribhai</surname> <given-names>D</given-names></name><name><surname>Relland</surname> <given-names>LM</given-names></name><name><surname>Truong</surname> <given-names>N</given-names></name><name><surname>Carlson</surname> <given-names>MR</given-names></name><name><surname>Williams</surname> <given-names>CB</given-names></name><name><surname>Chatila</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulatory T cell development in the absence of functional Foxp3</article-title><source>Nature Immunology</source><volume>8</volume><fpage>359</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1038/ni1445</pub-id><pub-id pub-id-type="pmid">17273171</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liston</surname> <given-names>A</given-names></name><name><surname>Nutsch</surname> <given-names>KM</given-names></name><name><surname>Farr</surname> <given-names>AG</given-names></name><name><surname>Lund</surname> <given-names>JM</given-names></name><name><surname>Rasmussen</surname> <given-names>JP</given-names></name><name><surname>Koni</surname> <given-names>PA</given-names></name><name><surname>Rudensky</surname> <given-names>AY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Differentiation of regulatory Foxp3+ T cells in the thymic cortex</article-title><source>PNAS</source><volume>105</volume><fpage>11903</fpage><lpage>11908</lpage><pub-id pub-id-type="doi">10.1073/pnas.0801506105</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loschko</surname> <given-names>J</given-names></name><name><surname>Schreiber</surname> <given-names>HA</given-names></name><name><surname>Rieke</surname> <given-names>GJ</given-names></name><name><surname>Esterházy</surname> <given-names>D</given-names></name><name><surname>Meredith</surname> <given-names>MM</given-names></name><name><surname>Pedicord</surname> <given-names>VA</given-names></name><name><surname>Yao</surname> <given-names>K-H</given-names></name><name><surname>Caballero</surname> <given-names>S</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name><name><surname>Mucida</surname> <given-names>D</given-names></name><name><surname>Nussenzweig</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Absence of MHC class II on cDCs results in microbial-dependent intestinal inflammation</article-title><source>Journal of Experimental Medicine</source><volume>213</volume><fpage>517</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1084/jem.20160062</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marie</surname> <given-names>JC</given-names></name><name><surname>Letterio</surname> <given-names>JJ</given-names></name><name><surname>Gavin</surname> <given-names>M</given-names></name><name><surname>Rudensky</surname> <given-names>AY</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells</article-title><source>Journal of Experimental Medicine</source><volume>201</volume><fpage>1061</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1084/jem.20042276</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matteoli</surname> <given-names>G</given-names></name><name><surname>Mazzini</surname> <given-names>E</given-names></name><name><surname>Iliev</surname> <given-names>ID</given-names></name><name><surname>Mileti</surname> <given-names>E</given-names></name><name><surname>Fallarino</surname> <given-names>F</given-names></name><name><surname>Puccetti</surname> <given-names>P</given-names></name><name><surname>Chieppa</surname> <given-names>M</given-names></name><name><surname>Rescigno</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction</article-title><source>Gut</source><volume>59</volume><fpage>595</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1136/gut.2009.185108</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzini</surname> <given-names>E</given-names></name><name><surname>Massimiliano</surname> <given-names>L</given-names></name><name><surname>Penna</surname> <given-names>G</given-names></name><name><surname>Rescigno</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Oral tolerance can be established via gap junction transfer of fed antigens from CX3CR1⁺ macrophages to CD103⁺ dendritic cells</article-title><source>Immunity</source><volume>40</volume><fpage>248</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.12.012</pub-id><pub-id pub-id-type="pmid">24462723</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDole</surname> <given-names>JR</given-names></name><name><surname>Wheeler</surname> <given-names>LW</given-names></name><name><surname>McDonald</surname> <given-names>KG</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Konjufca</surname> <given-names>V</given-names></name><name><surname>Knoop</surname> <given-names>KA</given-names></name><name><surname>Newberry</surname> <given-names>RD</given-names></name><name><surname>Miller</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine</article-title><source>Nature</source><volume>483</volume><fpage>345</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1038/nature10863</pub-id><pub-id pub-id-type="pmid">22422267</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melton</surname> <given-names>AC</given-names></name><name><surname>Bailey-Bucktrout</surname> <given-names>SL</given-names></name><name><surname>Travis</surname> <given-names>MA</given-names></name><name><surname>Fife</surname> <given-names>BT</given-names></name><name><surname>Bluestone</surname> <given-names>JA</given-names></name><name><surname>Sheppard</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice</article-title><source>Journal of Clinical Investigation</source><volume>120</volume><fpage>4436</fpage><lpage>4444</lpage><pub-id pub-id-type="doi">10.1172/JCI43786</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikulski</surname> <given-names>Z</given-names></name><name><surname>Johnson</surname> <given-names>R</given-names></name><name><surname>Shaked</surname> <given-names>I</given-names></name><name><surname>Kim</surname> <given-names>G</given-names></name><name><surname>Nowyhed</surname> <given-names>H</given-names></name><name><surname>Goodman</surname> <given-names>W</given-names></name><name><surname>Chodaczek</surname> <given-names>G</given-names></name><name><surname>Pizarro</surname> <given-names>TT</given-names></name><name><surname>Cominelli</surname> <given-names>F</given-names></name><name><surname>Ley</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SAMP1/YitFc mice develop ileitis via loss of CCL21 and defects in dendritic cell migration</article-title><source>Gastroenterology</source><volume>148</volume><fpage>783</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2015.01.027</pub-id><pub-id pub-id-type="pmid">25620669</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname> <given-names>DG</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name><name><surname>Kaminski</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Shapiro</surname> <given-names>SD</given-names></name><name><surname>Dolganov</surname> <given-names>G</given-names></name><name><surname>Glick</surname> <given-names>A</given-names></name><name><surname>Sheppard</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema</article-title><source>Nature</source><volume>422</volume><fpage>169</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1038/nature01413</pub-id><pub-id pub-id-type="pmid">12634787</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mowat</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>To respond or not to respond - a personal perspective of intestinal tolerance</article-title><source>Nature Reviews Immunology</source><volume>18</volume><fpage>405</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1038/s41577-018-0002-x</pub-id><pub-id pub-id-type="pmid">29491358</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nirschl</surname> <given-names>CJ</given-names></name><name><surname>Suárez-Fariñas</surname> <given-names>M</given-names></name><name><surname>Izar</surname> <given-names>B</given-names></name><name><surname>Prakadan</surname> <given-names>S</given-names></name><name><surname>Dannenfelser</surname> <given-names>R</given-names></name><name><surname>Tirosh</surname> <given-names>I</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Zhu</surname> <given-names>Q</given-names></name><name><surname>Devi</surname> <given-names>KSP</given-names></name><name><surname>Carroll</surname> <given-names>SL</given-names></name><name><surname>Chau</surname> <given-names>D</given-names></name><name><surname>Rezaee</surname> <given-names>M</given-names></name><name><surname>Kim</surname> <given-names>T-G</given-names></name><name><surname>Huang</surname> <given-names>R</given-names></name><name><surname>Fuentes-Duculan</surname> <given-names>J</given-names></name><name><surname>Song-Zhao</surname> <given-names>GX</given-names></name><name><surname>Gulati</surname> <given-names>N</given-names></name><name><surname>Lowes</surname> <given-names>MA</given-names></name><name><surname>King</surname> <given-names>SL</given-names></name><name><surname>Quintana</surname> <given-names>FJ</given-names></name><name><surname>Lee</surname> <given-names>Y</given-names></name><name><surname>Krueger</surname> <given-names>JG</given-names></name><name><surname>Sarin</surname> <given-names>KY</given-names></name><name><surname>Yoon</surname> <given-names>CH</given-names></name><name><surname>Garraway</surname> <given-names>L</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Shalek</surname> <given-names>AK</given-names></name><name><surname>Troyanskaya</surname> <given-names>O</given-names></name><name><surname>Anandasabapathy</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>IFNγ-Dependent Tissue-Immune homeostasis is Co-opted in the tumor microenvironment</article-title><source>Cell</source><volume>170</volume><fpage>127</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.06.016</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nutsch</surname> <given-names>K</given-names></name><name><surname>Chai</surname> <given-names>JN</given-names></name><name><surname>Ai</surname> <given-names>TL</given-names></name><name><surname>Russler-Germain</surname> <given-names>E</given-names></name><name><surname>Feehley</surname> <given-names>T</given-names></name><name><surname>Nagler</surname> <given-names>CR</given-names></name><name><surname>Hsieh</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Rapid and efficient generation of regulatory T cells to commensal antigens in the periphery</article-title><source>Cell Reports</source><volume>17</volume><fpage>206</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.08.092</pub-id><pub-id pub-id-type="pmid">27681432</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohl</surname> <given-names>L</given-names></name><name><surname>Mohaupt</surname> <given-names>M</given-names></name><name><surname>Czeloth</surname> <given-names>N</given-names></name><name><surname>Hintzen</surname> <given-names>G</given-names></name><name><surname>Kiafard</surname> <given-names>Z</given-names></name><name><surname>Zwirner</surname> <given-names>J</given-names></name><name><surname>Blankenstein</surname> <given-names>T</given-names></name><name><surname>Henning</surname> <given-names>G</given-names></name><name><surname>Förster</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions</article-title><source>Immunity</source><volume>21</volume><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.06.014</pub-id><pub-id pub-id-type="pmid">15308107</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orabona</surname> <given-names>C</given-names></name><name><surname>Puccetti</surname> <given-names>P</given-names></name><name><surname>Vacca</surname> <given-names>C</given-names></name><name><surname>Bicciato</surname> <given-names>S</given-names></name><name><surname>Luchini</surname> <given-names>A</given-names></name><name><surname>Fallarino</surname> <given-names>F</given-names></name><name><surname>Bianchi</surname> <given-names>R</given-names></name><name><surname>Velardi</surname> <given-names>E</given-names></name><name><surname>Perruccio</surname> <given-names>K</given-names></name><name><surname>Velardi</surname> <given-names>A</given-names></name><name><surname>Bronte</surname> <given-names>V</given-names></name><name><surname>Fioretti</surname> <given-names>MC</given-names></name><name><surname>Grohmann</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Toward the identification of a tolerogenic signature in IDO-competent dendritic cells</article-title><source>Blood</source><volume>107</volume><fpage>2846</fpage><lpage>2854</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-10-4077</pub-id><pub-id pub-id-type="pmid">16339401</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persson</surname> <given-names>EK</given-names></name><name><surname>Uronen-Hansson</surname> <given-names>H</given-names></name><name><surname>Semmrich</surname> <given-names>M</given-names></name><name><surname>Rivollier</surname> <given-names>A</given-names></name><name><surname>Hägerbrand</surname> <given-names>K</given-names></name><name><surname>Marsal</surname> <given-names>J</given-names></name><name><surname>Gudjonsson</surname> <given-names>S</given-names></name><name><surname>Håkansson</surname> <given-names>U</given-names></name><name><surname>Reizis</surname> <given-names>B</given-names></name><name><surname>Kotarsky</surname> <given-names>K</given-names></name><name><surname>Agace</surname> <given-names>WW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation</article-title><source>Immunity</source><volume>38</volume><fpage>958</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.03.009</pub-id><pub-id pub-id-type="pmid">23664832</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pezoldt</surname> <given-names>J</given-names></name><name><surname>Pasztoi</surname> <given-names>M</given-names></name><name><surname>Zou</surname> <given-names>M</given-names></name><name><surname>Wiechers</surname> <given-names>C</given-names></name><name><surname>Beckstette</surname> <given-names>M</given-names></name><name><surname>Thierry</surname> <given-names>GR</given-names></name><name><surname>Vafadarnejad</surname> <given-names>E</given-names></name><name><surname>Floess</surname> <given-names>S</given-names></name><name><surname>Arampatzi</surname> <given-names>P</given-names></name><name><surname>Buettner</surname> <given-names>M</given-names></name><name><surname>Schweer</surname> <given-names>J</given-names></name><name><surname>Fleissner</surname> <given-names>D</given-names></name><name><surname>Vital</surname> <given-names>M</given-names></name><name><surname>Pieper</surname> <given-names>DH</given-names></name><name><surname>Basic</surname> <given-names>M</given-names></name><name><surname>Dersch</surname> <given-names>P</given-names></name><name><surname>Strowig</surname> <given-names>T</given-names></name><name><surname>Hornef</surname> <given-names>M</given-names></name><name><surname>Bleich</surname> <given-names>A</given-names></name><name><surname>Bode</surname> <given-names>U</given-names></name><name><surname>Pabst</surname> <given-names>O</given-names></name><name><surname>Bajénoff</surname> <given-names>M</given-names></name><name><surname>Saliba</surname> <given-names>A-E</given-names></name><name><surname>Huehn</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neonatally imprinted stromal cell subsets induce tolerogenic dendritic cells in mesenteric lymph nodes</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>3903</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06423-7</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recordati</surname> <given-names>C</given-names></name><name><surname>Gualdi</surname> <given-names>V</given-names></name><name><surname>Craven</surname> <given-names>M</given-names></name><name><surname>Sala</surname> <given-names>L</given-names></name><name><surname>Luini</surname> <given-names>M</given-names></name><name><surname>Lanzoni</surname> <given-names>A</given-names></name><name><surname>Rishniw</surname> <given-names>M</given-names></name><name><surname>Simpson</surname> <given-names>KW</given-names></name><name><surname>Scanziani</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Spatial distribution of <italic>Helicobacter</italic> spp in the gastrointestinal tract of dogs</article-title><source>Helicobacter</source><volume>14</volume><fpage>180</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1111/j.1523-5378.2009.00674.x</pub-id><pub-id pub-id-type="pmid">19702848</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Kc</surname> <given-names>W</given-names></name><name><surname>Albring</surname> <given-names>JC</given-names></name><name><surname>Edelson</surname> <given-names>BT</given-names></name><name><surname>Kretzer</surname> <given-names>NM</given-names></name><name><surname>Bhattacharya</surname> <given-names>D</given-names></name><name><surname>Murphy</surname> <given-names>TL</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages</article-title><source>Journal of Experimental Medicine</source><volume>209</volume><fpage>1135</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1084/jem.20120030</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Briseño</surname> <given-names>CG</given-names></name><name><surname>Lee</surname> <given-names>JS</given-names></name><name><surname>Ng</surname> <given-names>D</given-names></name><name><surname>Manieri</surname> <given-names>NA</given-names></name><name><surname>Kc</surname> <given-names>W</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Thomas</surname> <given-names>SR</given-names></name><name><surname>Lee</surname> <given-names>W-L</given-names></name><name><surname>Turkoz</surname> <given-names>M</given-names></name><name><surname>McDonald</surname> <given-names>KG</given-names></name><name><surname>Meredith</surname> <given-names>MM</given-names></name><name><surname>Song</surname> <given-names>C</given-names></name><name><surname>Guidos</surname> <given-names>CJ</given-names></name><name><surname>Newberry</surname> <given-names>RD</given-names></name><name><surname>Ouyang</surname> <given-names>W</given-names></name><name><surname>Murphy</surname> <given-names>TL</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name><name><surname>Gommerman</surname> <given-names>JL</given-names></name><name><surname>Nussenzweig</surname> <given-names>MC</given-names></name><name><surname>Colonna</surname> <given-names>M</given-names></name><name><surname>Kopan</surname> <given-names>R</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens</article-title><source>Nature Immunology</source><volume>14</volume><fpage>937</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1038/ni.2679</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname> <given-names>CL</given-names></name><name><surname>Aumeunier</surname> <given-names>AM</given-names></name><name><surname>Mowat</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Intestinal CD103+ dendritic cells: master regulators of tolerance?</article-title><source>Trends in Immunology</source><volume>32</volume><fpage>412</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/j.it.2011.06.003</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shale</surname> <given-names>M</given-names></name><name><surname>Schiering</surname> <given-names>C</given-names></name><name><surname>Powrie</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CD4 <sup>+</sup> T-cell subsets in intestinal inflammation</article-title><source>Immunological Reviews</source><volume>252</volume><fpage>164</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1111/imr.12039</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sixt</surname> <given-names>M</given-names></name><name><surname>Kanazawa</surname> <given-names>N</given-names></name><name><surname>Selg</surname> <given-names>M</given-names></name><name><surname>Samson</surname> <given-names>T</given-names></name><name><surname>Roos</surname> <given-names>G</given-names></name><name><surname>Reinhardt</surname> <given-names>DP</given-names></name><name><surname>Pabst</surname> <given-names>R</given-names></name><name><surname>Lutz</surname> <given-names>MB</given-names></name><name><surname>Sorokin</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node</article-title><source>Immunity</source><volume>22</volume><fpage>19</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.11.013</pub-id><pub-id pub-id-type="pmid">15664156</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>C-M</given-names></name><name><surname>Hall</surname> <given-names>JA</given-names></name><name><surname>Blank</surname> <given-names>RB</given-names></name><name><surname>Bouladoux</surname> <given-names>N</given-names></name><name><surname>Oukka</surname> <given-names>M</given-names></name><name><surname>Mora</surname> <given-names>JR</given-names></name><name><surname>Belkaid</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid</article-title><source>Journal of Experimental Medicine</source><volume>204</volume><fpage>1775</fpage><lpage>1785</lpage><pub-id pub-id-type="doi">10.1084/jem.20070602</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takenaka</surname> <given-names>MC</given-names></name><name><surname>Quintana</surname> <given-names>FJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Tolerogenic dendritic cells</article-title><source>Seminars in Immunopathology</source><volume>39</volume><fpage>113</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1007/s00281-016-0587-8</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Development and maintenance of intestinal regulatory T cells</article-title><source>Nature Reviews Immunology</source><volume>16</volume><fpage>295</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.36</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatler</surname> <given-names>AL</given-names></name><name><surname>Goodwin</surname> <given-names>AT</given-names></name><name><surname>Gbolahan</surname> <given-names>O</given-names></name><name><surname>Saini</surname> <given-names>G</given-names></name><name><surname>Porte</surname> <given-names>J</given-names></name><name><surname>John</surname> <given-names>AE</given-names></name><name><surname>Clifford</surname> <given-names>RL</given-names></name><name><surname>Violette</surname> <given-names>SM</given-names></name><name><surname>Weinreb</surname> <given-names>PH</given-names></name><name><surname>Parfrey</surname> <given-names>H</given-names></name><name><surname>Wolters</surname> <given-names>PJ</given-names></name><name><surname>Gauldie</surname> <given-names>J</given-names></name><name><surname>Kolb</surname> <given-names>M</given-names></name><name><surname>Jenkins</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Amplification of tgfβ induced ITGB6 gene transcription may promote pulmonary fibrosis</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0158047</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0158047</pub-id><pub-id pub-id-type="pmid">27494713</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>NS</given-names></name><name><surname>Xu</surname> <given-names>S</given-names></name><name><surname>Nambiar</surname> <given-names>P</given-names></name><name><surname>Dewhirst</surname> <given-names>FE</given-names></name><name><surname>Fox</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and north america</article-title><source>Journal of Clinical Microbiology</source><volume>45</volume><fpage>2166</fpage><lpage>2172</lpage><pub-id pub-id-type="doi">10.1128/JCM.00137-07</pub-id><pub-id pub-id-type="pmid">17507523</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornton</surname> <given-names>AM</given-names></name><name><surname>Korty</surname> <given-names>PE</given-names></name><name><surname>Tran</surname> <given-names>DQ</given-names></name><name><surname>Wohlfert</surname> <given-names>EA</given-names></name><name><surname>Murray</surname> <given-names>PE</given-names></name><name><surname>Belkaid</surname> <given-names>Y</given-names></name><name><surname>Shevach</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Expression of Helios, an ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3<sup>+</sup> T regulatory cells</article-title><source>The Journal of Immunology</source><volume>184</volume><fpage>3433</fpage><lpage>3441</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0904028</pub-id><pub-id pub-id-type="pmid">20181882</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travis</surname> <given-names>MA</given-names></name><name><surname>Reizis</surname> <given-names>B</given-names></name><name><surname>Melton</surname> <given-names>AC</given-names></name><name><surname>Masteller</surname> <given-names>E</given-names></name><name><surname>Tang</surname> <given-names>Q</given-names></name><name><surname>Proctor</surname> <given-names>JM</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Bernstein</surname> <given-names>X</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name><name><surname>Reichardt</surname> <given-names>LF</given-names></name><name><surname>Bluestone</surname> <given-names>JA</given-names></name><name><surname>Sheppard</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice</article-title><source>Nature</source><volume>449</volume><fpage>361</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1038/nature06110</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tussiwand</surname> <given-names>R</given-names></name><name><surname>Lee</surname> <given-names>W-L</given-names></name><name><surname>Murphy</surname> <given-names>TL</given-names></name><name><surname>Mashayekhi</surname> <given-names>M</given-names></name><name><surname>Kc</surname> <given-names>W</given-names></name><name><surname>Albring</surname> <given-names>JC</given-names></name><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Rotondo</surname> <given-names>JA</given-names></name><name><surname>Edelson</surname> <given-names>BT</given-names></name><name><surname>Kretzer</surname> <given-names>NM</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Weiss</surname> <given-names>LA</given-names></name><name><surname>Glasmacher</surname> <given-names>E</given-names></name><name><surname>Li</surname> <given-names>P</given-names></name><name><surname>Liao</surname> <given-names>W</given-names></name><name><surname>Behnke</surname> <given-names>M</given-names></name><name><surname>Lam</surname> <given-names>SSK</given-names></name><name><surname>Aurthur</surname> <given-names>CT</given-names></name><name><surname>Leonard</surname> <given-names>WJ</given-names></name><name><surname>Singh</surname> <given-names>H</given-names></name><name><surname>Stallings</surname> <given-names>CL</given-names></name><name><surname>Sibley</surname> <given-names>LD</given-names></name><name><surname>Schreiber</surname> <given-names>RD</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Compensatory dendritic cell development mediated by BATF–IRF interactions</article-title><source>Nature</source><volume>490</volume><fpage>502</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1038/nature11531</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tussiwand</surname> <given-names>R</given-names></name><name><surname>Everts</surname> <given-names>B</given-names></name><name><surname>Grajales-Reyes</surname> <given-names>GE</given-names></name><name><surname>Kretzer</surname> <given-names>NM</given-names></name><name><surname>Iwata</surname> <given-names>A</given-names></name><name><surname>Bagaitkar</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Wong</surname> <given-names>R</given-names></name><name><surname>Anderson</surname> <given-names>DA</given-names></name><name><surname>Murphy</surname> <given-names>TL</given-names></name><name><surname>Pearce</surname> <given-names>EJ</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses</article-title><source>Immunity</source><volume>42</volume><fpage>916</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.04.017</pub-id><pub-id pub-id-type="pmid">25992862</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uematsu</surname> <given-names>S</given-names></name><name><surname>Fujimoto</surname> <given-names>K</given-names></name><name><surname>Jang</surname> <given-names>MH</given-names></name><name><surname>Yang</surname> <given-names>B-G</given-names></name><name><surname>Jung</surname> <given-names>Y-J</given-names></name><name><surname>Nishiyama</surname> <given-names>M</given-names></name><name><surname>Sato</surname> <given-names>S</given-names></name><name><surname>Tsujimura</surname> <given-names>T</given-names></name><name><surname>Yamamoto</surname> <given-names>M</given-names></name><name><surname>Yokota</surname> <given-names>Y</given-names></name><name><surname>Kiyono</surname> <given-names>H</given-names></name><name><surname>Miyasaka</surname> <given-names>M</given-names></name><name><surname>Ishii</surname> <given-names>KJ</given-names></name><name><surname>Akira</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5</article-title><source>Nature Immunology</source><volume>9</volume><fpage>769</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1038/ni.1622</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veenbergen</surname> <given-names>S</given-names></name><name><surname>van Berkel</surname> <given-names>LA</given-names></name><name><surname>du Pré</surname> <given-names>MF</given-names></name><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Karrich</surname> <given-names>JJ</given-names></name><name><surname>Costes</surname> <given-names>LM</given-names></name><name><surname>Luk</surname> <given-names>F</given-names></name><name><surname>Simons-Oosterhuis</surname> <given-names>Y</given-names></name><name><surname>Raatgeep</surname> <given-names>HC</given-names></name><name><surname>Cerovic</surname> <given-names>V</given-names></name><name><surname>Cupedo</surname> <given-names>T</given-names></name><name><surname>Mowat</surname> <given-names>AM</given-names></name><name><surname>Kelsall</surname> <given-names>BL</given-names></name><name><surname>Samsom</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Colonic tolerance develops in the iliac lymph nodes and can be established independent of CD103(+) dendritic cells</article-title><source>Mucosal Immunology</source><volume>9</volume><fpage>894</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1038/mi.2015.118</pub-id><pub-id pub-id-type="pmid">26577569</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>J</given-names></name><name><surname>Duramad</surname> <given-names>O</given-names></name><name><surname>Perng</surname> <given-names>OA</given-names></name><name><surname>Reiner</surname> <given-names>SL</given-names></name><name><surname>Liu</surname> <given-names>Y-J</given-names></name><name><surname>Qin</surname> <given-names>FX-F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells</article-title><source>PNAS</source><volume>104</volume><fpage>18169</fpage><lpage>18174</lpage><pub-id pub-id-type="doi">10.1073/pnas.0703642104</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welty</surname> <given-names>NE</given-names></name><name><surname>Staley</surname> <given-names>C</given-names></name><name><surname>Ghilardi</surname> <given-names>N</given-names></name><name><surname>Sadowsky</surname> <given-names>MJ</given-names></name><name><surname>Igyártó</surname> <given-names>BZ</given-names></name><name><surname>Kaplan</surname> <given-names>DH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Intestinal lamina propria dendritic cells maintain T cell homeostasis but do not affect commensalism</article-title><source>Journal of Experimental Medicine</source><volume>210</volume><fpage>2011</fpage><lpage>2024</lpage><pub-id pub-id-type="doi">10.1084/jem.20130728</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worbs</surname> <given-names>T</given-names></name><name><surname>Bode</surname> <given-names>U</given-names></name><name><surname>Yan</surname> <given-names>S</given-names></name><name><surname>Hoffmann</surname> <given-names>MW</given-names></name><name><surname>Hintzen</surname> <given-names>G</given-names></name><name><surname>Bernhardt</surname> <given-names>G</given-names></name><name><surname>Förster</surname> <given-names>R</given-names></name><name><surname>Pabst</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells</article-title><source>Journal of Experimental Medicine</source><volume>203</volume><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1084/jem.20052016</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname> <given-names>C</given-names></name><name><surname>Sugiyama</surname> <given-names>M</given-names></name><name><surname>Ohta</surname> <given-names>T</given-names></name><name><surname>Hemmi</surname> <given-names>H</given-names></name><name><surname>Hamada</surname> <given-names>E</given-names></name><name><surname>Sasaki</surname> <given-names>I</given-names></name><name><surname>Fukuda</surname> <given-names>Y</given-names></name><name><surname>Yano</surname> <given-names>T</given-names></name><name><surname>Nobuoka</surname> <given-names>M</given-names></name><name><surname>Hirashima</surname> <given-names>T</given-names></name><name><surname>Iizuka</surname> <given-names>A</given-names></name><name><surname>Sato</surname> <given-names>K</given-names></name><name><surname>Tanaka</surname> <given-names>T</given-names></name><name><surname>Hoshino</surname> <given-names>K</given-names></name><name><surname>Kaisho</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1</article-title><source>The Journal of Immunology</source><volume>190</volume><fpage>6071</fpage><lpage>6082</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202798</pub-id><pub-id pub-id-type="pmid">23670193</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>H</given-names></name><name><surname>Zou</surname> <given-names>S</given-names></name><name><surname>Lan</surname> <given-names>Y</given-names></name><name><surname>Fei</surname> <given-names>W</given-names></name><name><surname>Jiang</surname> <given-names>R</given-names></name><name><surname>Hu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Smad7 modulates tgfβ signaling during cranial suture development to maintain suture patency</article-title><source>Journal of Bone and Mineral Research</source><volume>29</volume><fpage>716</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1002/jbmr.2066</pub-id><pub-id pub-id-type="pmid">23959527</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.54792.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>MacPherson</surname><given-names>Andrew J</given-names></name><role>Reviewing Editor</role><aff><institution>University of Bern</institution><country>Switzerland</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>We appreciated the investigation of the nature of the dendritic cell subset involved in regulating immune responses to <italic>Helicobacter</italic> spp in mouse colonies showing that under normal conditions, a variety of DC subsets may drive the generation of peripheral regulatory T cells and confirming that this is not necessarily a specific property of CD103<sup>+</sup> DC. Under inflammatory conditions, the development of Treg may be over-ridden by effector T cell differentiation, despite the presence of tolerogenic DC.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Gut <italic>Helicobacter</italic> presentation by multiple dendritic cell subsets enables context-specific regulatory T cell generation&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Wendy Garrett as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and we have drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>In this paper, Russler-Germain et al. explore the nature of the dendritic cell subset involved in regulating immune responses to <italic>Helicobacter</italic> spp in the mouse colon. By examining the anatomically appropriate draining lymph node, the authors conclude that under normal conditions, a variety of DC subsets may drive the generation of regulatory T cells and that this is not a specific property of CD103<sup>+</sup> DC as has been proposed previously. Indeed, CD103-CD11b<sup>+</sup> DC may be the most effective subset in this respect. Under inflammatory conditions, the usual development of Treg may be over-ridden, despite the presence of tolerogenic DC. Herein, the authors propose an interesting hypothesis in which tolerance is a &quot;recessive&quot; phenomenon. The work uses a variety of animal models to dissect individual DC subsets in selective ways and analyses the resulting findings with caution, which is commendable. Although many of the results are negative, they are important, as they challenge several previous assumptions about tolerance to intestinal antigens that were often made based on less specific models or on use of anatomically less precise tissues. However, the work also supports an earlier finding that there may be flexibility among DC subsets in their ability to drive Treg cells against protein antigens in different segments of the intestine, with CD103-CD11b<sup>+</sup> DC appearing to be particularly important in the colon. There are also a number of useful cautionary points raised about models used to assess DC subset function, generation of Treg and tolerance in this manuscript.</p><p>Essential revisions:</p><p>We appreciated the conclusion that no single DC subset can account for tolerance in the intestine given the paradigm of CD103<sup>+</sup> &quot;tolerogenic&quot; DC in other papers. We also appreciated the fact that the authors had attempted to improve on previous approaches for depleting individual DC subsets in vivo.</p><p>1) Whilst we felt the overall message was important and would be a useful addition to the field there are concerns that the current work cannot exclude possible roles for contaminating cells from other phenotypic subsets and that in a number of places the results are over-interpreted. The major issue is therefore not with the data as such, but with the authors' strong counter-dogmatic interpretations that likely remain open to dispute. The reviewers agree that the work would be acceptable if presented with very clear caveats rather than &quot;dogma challenging.&quot; A number of previous studies have also provided evidence that there is redundancy in the ability of different DC subsets to induce Treg differentiation. These previous studies have obvious caveats (explored in the Introduction), but the current study does not entirely eliminate such issues. We therefore ask that the interpretations, discussion and conclusions need to be more nuanced throughout.</p><p>2) The authors are obviously fully aware of the heterogeneity amongst the population referred to as &quot;CD103<sup>+</sup> DC&quot; and indeed, address this issue experimentally. However it would be appropriate for this to be highlighted from the earliest stage of the manuscript, particularly when referring to the earlier in vivo and in vitro studies that did not discriminate between the CD103<sup>+</sup>CD11b<sup>+</sup> and CD103<sup>+</sup>CD11b- subsets present amongst this population. Ideally this would mean defining throughout which subsets of CD103<sup>+</sup> DC had been used, employing the cDC1 and cDC2 nomenclature that has become standard.</p><p>While the evidence that CD103-CD11b<sup>+</sup> DC play a more significant role than anticipated is fairly persuasive, some of the data used to support this idea are somewhat over-interpreted. For instance, these cells actually express very few of the molecules that are associated with &quot;tolerogenic&quot; DC in the intestine, such as b8 integrin, RALDH, IDO. This should be acknowledged, as should the findings that confirm previous work showing that cDC1 are the population expressing some of these molecules such as b8 and RALDH.</p><p>3) Both CD103<sup>+</sup>CD11b- and CD103<sup>+</sup>CD11b<sup>+</sup> subsets have been proposed to contribute to pTreg generation, so it is not necessarily surprising that the models used by the authors to deplete one or the other of these subsets ( Irf8 +32 5'<sup>-/-</sup>, hLangDTA, Irf4ΔDC, Notch2ΔDC) do not affect the frequency of Helicobacter-specific pTreg cell generation. Particularly since the loss of one CD103<sup>+</sup> population is often compensated for by an increase in the other. The key experiment therefore becomes the Irf8 +32 5'<sup>-/-</sup> hLangDTA cross, which depletes both CD103<sup>+</sup> subsets. However, even in this model ~20% of the remaining DCs are CD103<sup>+</sup> (total numbers reduced from 30,000 to 10,000) so it is difficult to see how this data supports the authors conclusion that &quot;Contrary to the prevailing notion suggesting that CD103<sup>+</sup> DCs are important, loss of these DCs in vivo using genetic models did not affect the frequency of Helicobacter-specific pTreg cell generation.&quot; Were the remaining CD103<sup>+</sup> SP and DP DCs analysed in these mice to determine if they could still looked like their WT counterparts (as in Figure 6) or could still efficiently induce Foxp3 expression in vitro? I feel that the conclusions of the paper should be softened to account for this issue.</p><p>4) While clearly a more effective system to target both the cDC1 and cDC2 subsets of CD103<sup>+</sup> DC, it has to be acknowledged that some of both subset remain in the hLangDTA Irf8 +32 5'<sup>-/-</sup> mice.</p><p>5) The extent of <italic>Helicobacter</italic> colonisation in the mice and composition of the microbiota needs to be reported. One aspect which is not mentioned is whether any of the various deletional models might be influenced by the microbiome which is likely to be distinct in different laboratories using the same strains. In this respect, do the authors have any information on the composition of the microbiota in their different strains used here?</p><p>6) The immunohistology analysis was thought to be fraught with potential confounding issues and should be removed.</p><p>7) Whilst the authors acknowledge that 15-25% of CD103-CD11b<sup>+</sup> cells are likely to be macrophages, this needs to be more clearly emphasised and discussed.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for submitting your article &quot;Gut <italic>Helicobacter</italic> presentation by multiple dendritic cell subsets enables context-specific regulatory T cell generation&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two reviewers, and the evaluation has been overseen by a Reviewing Editor and Wendy Garrett as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as <italic>eLife</italic> papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity over claims and caveats in interpretation.</p><p>The manuscript provides potentially important data on the nature of the dendritic cell which is responsible for maintaining immunological tolerance against bacteria in the intestine. The data support the view that each of the several subsets of dendritic cells can generate regulatory T cells under different circumstances, indicating the flexibility of the dendritic cell population and the importance of having redundant mechanisms to maintain tolerance in this tissue.</p><p>Summary:</p><p>The authors are thanked for their replies to the original comments and for the additional experimental data they have provided. Overall, the manuscript was considered much improved and the conclusions that intestinal DC subsets may have overlapping abilities to induce regulatory T cells are substantiated better.</p><p>Revisions:</p><p>We would be glad if the authors could address the following issues mainly in the text to provide appropriate caveats of the interpretations of their data and acknowledgement of the contributions already available in the literature. There is also one additional point of negative controls which should be provided.</p><p>No negative controls are shown for T cells stimulated without DC or antigen are provided for the assays shown in Figure 2. This is important, as some of the proportions of CD25<sup>+</sup> T cells stimulated by the different DC subsets are low.</p><p>Other points to deal with caveats, interpretations and acknowledgments of other contributions.</p><p>1) It is probably fair to say that the authors have still not acknowledged fully that the idea of redundancy between intestinal DC functions is not as novel as they suggest. Furthermore, they do not state that the study by Veenbergen et al. cited here showed directly that CD103-CD11b<sup>+</sup> DC could induce tolerance to OVA in the colon, a finding that is replicated here for Helicobacter.</p><p>2) In respect of this subset, it is also still not acknowledged that these cells do not express significant levels of Aldh, Itgb8 and Ido, the mediators that have been most strongly associated with tolerogenic functions of DC.</p><p>3) Although the authors now show data indicating potential contamination of the CD103-CD11b<sup>+</sup> &quot;DC&quot; subset with macrophages, this finding is ignored subsequently in the manuscript. While this may not contradict the conclusion that no single subset of genuine DC can account for the generation of Treg, it does complicate interpretation of the studies of gene expression by sorted subsets. In particular, several of the genes interpreted as being potentially related to tolerance induction by CD103-CD11b<sup>+</sup> &quot;DC&quot; are characteristic of intestinal macrophages, including IL10, av integrin and TGFb.</p><p>4) While the findings presented here are highly important in showing that none of the conditional deletion strategies is fully effective in eliminating the relevant subset of DC, this does remain a critical issue in interpreting the current data and has not yet been acknowledged adequately.</p><p>5) The lack of control data from the straight Notch-2 δ DC mice remains an important caveat when interpreting the experiments in the double KO mice.</p><p>6) Were all the mice used at such young ages? If so, this difference between the current and previous studies warrants more detailed acknowledgement than here.</p><p>7) It is important to note that the studies of Treg induction by Coombes et al., 2007 and Sun et al., 2007 did not show a role for cDC1, as these experiments were performed using total CD103<sup>+</sup> DC and before it was appreciated that this population contained both cDC1 and cDC2.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.54792.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>We appreciated the conclusion that no single DC subset can account for tolerance in the intestine given the paradigm of CD103<sup>+</sup> &quot;tolerogenic&quot; DC in other papers. We also appreciated the fact that the authors had attempted to improve on previous approaches for depleting individual DC subsets in vivo.</p><p>1) Whilst we felt the overall message was important and would be a useful addition to the field there are concerns that the current work cannot exclude possible roles for contaminating cells from other phenotypic subsets and that in a number of places the results are over-interpreted. The major issue is therefore not with the data as such, but with the authors' strong counter-dogmatic interpretations that likely remain open to dispute. The reviewers agree that the work would be acceptable if presented with very clear caveats rather than &quot;dogma challenging.&quot; A number of previous studies have also provided evidence that there is redundancy in the ability of different DC subsets to induce Treg differentiation. These previous studies have obvious caveats (explored in the Introduction), but the current study does not entirely eliminate such issues. We therefore ask that the interpretations, discussion and conclusions need to be more nuanced throughout.</p></disp-quote><p>We have amended the manuscript to better reflect the nuances of the data. These changes include modifications to language in the Abstract, Results, and Discussion. We have also added this limitation to the Discussion.</p><disp-quote content-type="editor-comment"><p>2) The authors are obviously fully aware of the heterogeneity amongst the population referred to as &quot;CD103<sup>+</sup> DC&quot; and indeed, address this issue experimentally. However it would be appropriate for this to be highlighted from the earliest stage of the manuscript, particularly when referring to the earlier in vivo and in vitro studies that did not discriminate between the CD103<sup>+</sup>CD11b<sup>+</sup> and CD103<sup>+</sup>CD11b- subsets present amongst this population. Ideally this would mean defining throughout which subsets of CD103<sup>+</sup> DC had been used, employing the cDC1 and cDC2 nomenclature that has become standard.</p></disp-quote><p>We have amended the manuscript to include CD103<sup>+</sup> subset descriptions and cDC1/cDC2 nomenclature where appropriate.</p><disp-quote content-type="editor-comment"><p>While the evidence that CD103-CD11b<sup>+</sup> DC play a more significant role than anticipated is fairly persuasive, some of the data used to support this idea are somewhat over-interpreted. For instance, these cells actually express very few of the molecules that are associated with &quot;tolerogenic&quot; DC in the intestine, such as b8 integrin, RALDH, IDO. This should be acknowledged, as should the findings that confirm previous work showing that cDC1 are the population expressing some of these molecules such as b8 and RALDH.</p></disp-quote><p>As suggested, we have added additional discussion of these previous findings in the Results.</p><disp-quote content-type="editor-comment"><p>3) Both CD103<sup>+</sup>CD11b- and CD103<sup>+</sup>CD11b<sup>+</sup> subsets have been proposed to contribute to pTreg generation, so it is not necessarily surprising that the models used by the authors to deplete one or the other of these subsets ( Irf8 +32 5'<sup>-/-</sup>, hLangDTA, Irf4ΔDC, Notch2ΔDC) do not affect the frequency of Helicobacter-specific pTreg cell generation. Particularly since the loss of one CD103<sup>+</sup> population is often compensated for by an increase in the other. The key experiment therefore becomes the Irf8 +32 5'<sup>-/-</sup> hLangDTA cross, which depletes both CD103<sup>+</sup> subsets. However, even in this model ~20% of the remaining DCs are CD103<sup>+</sup> (total numbers reduced from 30,000 to 10,000) so it is difficult to see how this data supports the authors conclusion that &quot;Contrary to the prevailing notion suggesting that CD103<sup>+</sup> DCs are important, loss of these DCs in vivo using genetic models did not affect the frequency of Helicobacter-specific pTreg cell generation.&quot; Were the remaining CD103<sup>+</sup> SP and DP DCs analysed in these mice to determine if they could still looked like their WT counterparts (as in Figure 6) or could still efficiently induce Foxp3 expression in vitro? I feel that the conclusions of the paper should be softened to account for this issue.</p></disp-quote><p>We previously did not perform in vitro functional experiments using the remaining cDCs as their numbers were low. Therefore, we have softened the conclusions of the manuscript to account for this issue as discussed in response to point #1 above. As suggested, we performed analysis of TCR stimulation and tolerogenic markers in remaining CD103<sup>+</sup> cDC1s and cDC2s in CD207-DTA::<italic>Irf8</italic><sup>D149en/D149en</sup> mice. We found that the only marker that was significantly changed was CD86 expression, which was reduced in both subsets of cDCs in CD207-DTA::<italic>Irf8</italic><sup>D149en/D149en</sup> mice (Figure 6—figure supplement 2B).</p><disp-quote content-type="editor-comment"><p>4) While clearly a more effective system to target both the cDC1 and cDC2 subsets of CD103<sup>+</sup> DC, it has to be acknowledged that some of both subset remain in the hLangDTA Irf8 +32 5'<sup>-/-</sup> mice.</p></disp-quote><p>We have noted this issue more clearly in the text.</p><disp-quote content-type="editor-comment"><p>5) The extent of Helicobacter colonisation in the mice and composition of the microbiota needs to be reported. One aspect which is not mentioned is whether any of the various deletional models might be influenced by the microbiome which is likely to be distinct in different laboratories using the same strains. In this respect, do the authors have any information on the composition of the microbiota in their different strains used here?</p></disp-quote><p>As suggested, we analyzed bacterial microbiomes by 16S rRNA sequencing of colonic contents. We did not observe obvious differences in Shannon diversity or β diversity by Unifrac or Bray-Curtis NMDS. Frequencies of <italic>Helicobacter typhlonius</italic> and <italic>Helicobacter apodemus</italic> were not markedly impacted (Figure 6—figure supplement 1).</p><disp-quote content-type="editor-comment"><p>6) The immunohistology analysis was thought to be fraught with potential confounding issues and should be removed.</p></disp-quote><p>Although we believe that the immunohistochemistry showing no obvious physical associations of CT2 and CT6 with any migratory cDC subset in vivo was informative, we have removed these data and analysis from the manuscript as suggested.</p><disp-quote content-type="editor-comment"><p>7) Whilst the authors acknowledge that 15-25% of CD103-CD11b<sup>+</sup> cells are likely to be macrophages, this needs to be more clearly emphasised and discussed.</p></disp-quote><p>We have expanded our discussion of this topic in the Results section. In brief, we state that our previous in vivo data using <italic>Zbtb46<sup>DTR</sup></italic> mice showing the importance of Zbtb46<sup>+</sup> cells for in vivo CT2 and CT6 activation and pTreg cell generation (Nutsch et al., 2016) suggest that the Zbtb46<sup>GFP–</sup> cells in our sorted CD103<sup>–</sup>CD11b<sup>+</sup> APCs would not likely be a major contributor to in vitro responses.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>Revisions:</p><p>We would be glad if the authors could address the following issues mainly in the text to provide appropriate caveats of the interpretations of their data and acknowledgement of the contributions already available in the literature. There is also one additional point of negative controls which should be provided.</p><p>No negative controls are shown for T cells stimulated without DC or antigen are provided for the assays shown in Figure 2. This is important, as some of the proportions of CD25<sup>+</sup> T cells stimulated by the different DC subsets are low.</p></disp-quote><p>We routinely performed T cell only (no cDC) controls for the in vitro experiments and include these re-analysis resulting in changed Figure 1, Figure 2, Figure 1—figure supplement 1B, and Figure 7—figure supplement 1A,B. Data interpretations remained unchanged.</p><disp-quote content-type="editor-comment"><p>Other points to deal with caveats, interpretations and acknowledgments of other contributions.</p><p>1) It is probably fair to say that the authors have still not acknowledged fully that the idea of redundancy between intestinal DC functions is not as novel as they suggest. Furthermore, they do not state that the study by Veenbergen et al. cited here showed directly that CD103-CD11b<sup>+</sup> DC could induce tolerance to OVA in the colon, a finding that is replicated here for Helicobacter.</p></disp-quote><p>We have edited our Introduction to more clearly discuss the data presented by Veenbergen et al. (Introduction, Results and Discussion). Note that this study does not appear to show equivalent in vivo Foxp3 induction in <italic>Batf3</italic><sup>–/–</sup> vs WT mice, but only in vitro Foxp3 induction in the presence of TGFb. Equivalent functional tolerance in <italic>Batf3<sup>–/–</sup></italic> vs WT mice in vivo was reported.</p><disp-quote content-type="editor-comment"><p>2) In respect of this subset, it is also still not acknowledged that these cells do not express significant levels of Aldh, Itgb8 and Ido, the mediators that have been most strongly associated with tolerogenic functions of DC.</p></disp-quote><p>We have acknowledged these findings with our interpretation in the Discussion.</p><disp-quote content-type="editor-comment"><p>3) Although the authors now show data indicating potential contamination of the CD103-CD11b<sup>+</sup> &quot;DC&quot; subset with macrophages, this finding is ignored subsequently in the manuscript. While this may not contradict the conclusion that no single subset of genuine DC can account for the generation of Treg, it does complicate interpretation of the studies of gene expression by sorted subsets. In particular, several of the genes interpreted as being potentially related to tolerance induction by CD103-CD11b<sup>+</sup> &quot;DC&quot; are characteristic of intestinal macrophages, including IL10, av integrin and TGFb.</p></disp-quote><p>We have addressed this caveat in the text.</p><disp-quote content-type="editor-comment"><p>4) While the findings presented here are highly important in showing that none of the conditional deletion strategies is fully effective in eliminating the relevant subset of DC, this does remain a critical issue in interpreting the current data and has not yet been acknowledged adequately.</p></disp-quote><p>We have clarified this caveat in the Results and Discussion.</p><disp-quote content-type="editor-comment"><p>5) The lack of control data from the straight Notch-2 δ DC mice remains an important caveat when interpreting the experiments in the double KO mice.</p></disp-quote><p>We acknowledge that it would have been useful to also include experiments with <italic>Notch2<sup>fl/fl</sup></italic> controls from the same litters. Unfortunately, we do not have this breeding set up to address this concern. We believe that the manuscript does not depend on the <italic>Notch2</italic>-DDC data, so we have removed this data (Figure 4—figure supplement 2A–C were removed, with Figure 4—figure supplement 2D moved to Figure 4—figure supplement 1E).</p><disp-quote content-type="editor-comment"><p>6) Were all the mice used at such young ages? If so, this difference between the current and previous studies warrants more detailed acknowledgement than here.</p></disp-quote><p>We have added justification for our use of young host mice.</p><disp-quote content-type="editor-comment"><p>7) It is important to note that the studies of Treg induction by Coombes et al., 2007 and Sun et al., 2007 did not show a role for cDC1, as these experiments were performed using total CD103<sup>+</sup> DC and before it was appreciated that this population contained both cDC1 and cDC2.</p></disp-quote><p>We have clarified this important point in the Introduction.</p></body></sub-article></article>